<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE html><html xmlns="http://www.w3.org/1999/xhtml" xmlns:art="http://www.rsc.org/schema/rscart38" xmlns:epub="http://www.idpf.org/2007/ops" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:rsc="urn:rsc.org" xml:lang="en" lang="en"><head><!--Google Tag Manager--><script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
j=d.createElement(s),dl=l!='dataLayer'?'&amp;l='+l:'';j.async=true;j.src=
'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,'script','dataLayer','GTM-56FZ7G');</script><!--End Google Tag Manager--><title>Development of hydrophobic reduced graphene oxide as a new efficient approach for photochemotherapy   - RSC Advances (RSC Publishing) DOI:10.1039/D0RA00186D</title><link rel="canonical" href="https://pubs.rsc.org/en/content/articlehtml/2020/ra/d0ra00186d"/><meta http-equiv="content-type" content="application/xhtml+xml; charset=utf-8"/><script type="text/javascript">window.NREUM||(NREUM={});NREUM.info = {"beacon":"bam.nr-data.net","errorBeacon":"bam.nr-data.net","licenseKey":"NRJS-aaa897feae8feeca979","applicationID":"1313546638","transactionName":"M1wANxQFCEcDVU0PWgoWLzUlSyVbDEJcCEEnVgwXFAsKWAdEFgdHEFABDwMMElkO","queueTime":22,"applicationTime":106,"agent":"","atts":""}</script><script type="text/javascript">(window.NREUM||(NREUM={})).init={privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]},distributed_tracing:{enabled:true}};(window.NREUM||(NREUM={})).loader_config={agentID:"1386013924",accountID:"2851366",trustKey:"1029994",xpid:"Vg4CUFVVDhABV1BRAgUBUFcJ",licenseKey:"NRJS-aaa897feae8feeca979",applicationID:"1313546638"};window.NREUM||(NREUM={}),__nr_require=function(t,e,n){function r(n){if(!e[n]){var o=e[n]={exports:{}};t[n][0].call(o.exports,function(e){var o=t[n][1][e];return r(o||e)},o,o.exports)}return e[n].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<n.length;o++)r(n[o]);return r}({1:[function(t,e,n){function r(t){try{s.console&&console.log(t)}catch(e){}}var o,i=t("ee"),a=t(31),s={};try{o=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(s.console=!0,o.indexOf("dev")!==-1&&(s.dev=!0),o.indexOf("nr_dev")!==-1&&(s.nrDev=!0))}catch(c){}s.nrDev&&i.on("internal-error",function(t){r(t.stack)}),s.dev&&i.on("fn-err",function(t,e,n){r(n.stack)}),s.dev&&(r("NR AGENT IN DEVELOPMENT MODE"),r("flags: "+a(s,function(t,e){return t}).join(", ")))},{}],2:[function(t,e,n){function r(t,e,n,r,s){try{l?l-=1:o(s||new UncaughtException(t,e,n),!0)}catch(f){try{i("ierr",[f,c.now(),!0])}catch(d){}}return"function"==typeof u&&u.apply(this,a(arguments))}function UncaughtException(t,e,n){this.message=t||"Uncaught error with no additional information",this.sourceURL=e,this.line=n}function o(t,e){var n=e?null:c.now();i("err",[t,n])}var i=t("handle"),a=t(32),s=t("ee"),c=t("loader"),f=t("gos"),u=window.onerror,d=!1,p="nr@seenError";if(!c.disabled){var l=0;c.features.err=!0,t(1),window.onerror=r;try{throw new Error}catch(h){"stack"in h&&(t(14),t(13),"addEventListener"in window&&t(7),c.xhrWrappable&&t(15),d=!0)}s.on("fn-start",function(t,e,n){d&&(l+=1)}),s.on("fn-err",function(t,e,n){d&&!n[p]&&(f(n,p,function(){return!0}),this.thrown=!0,o(n))}),s.on("fn-end",function(){d&&!this.thrown&&l>0&&(l-=1)}),s.on("internal-error",function(t){i("ierr",[t,c.now(),!0])})}},{}],3:[function(t,e,n){var r=t("loader");r.disabled||(r.features.ins=!0)},{}],4:[function(t,e,n){function r(){U++,L=g.hash,this[u]=y.now()}function o(){U--,g.hash!==L&&i(0,!0);var t=y.now();this[h]=~~this[h]+t-this[u],this[d]=t}function i(t,e){E.emit("newURL",[""+g,e])}function a(t,e){t.on(e,function(){this[e]=y.now()})}var s="-start",c="-end",f="-body",u="fn"+s,d="fn"+c,p="cb"+s,l="cb"+c,h="jsTime",m="fetch",v="addEventListener",w=window,g=w.location,y=t("loader");if(w[v]&&y.xhrWrappable&&!y.disabled){var x=t(11),b=t(12),E=t(9),R=t(7),O=t(14),T=t(8),S=t(15),P=t(10),M=t("ee"),C=M.get("tracer"),N=t(23);t(17),y.features.spa=!0;var L,U=0;M.on(u,r),b.on(p,r),P.on(p,r),M.on(d,o),b.on(l,o),P.on(l,o),M.buffer([u,d,"xhr-resolved"]),R.buffer([u]),O.buffer(["setTimeout"+c,"clearTimeout"+s,u]),S.buffer([u,"new-xhr","send-xhr"+s]),T.buffer([m+s,m+"-done",m+f+s,m+f+c]),E.buffer(["newURL"]),x.buffer([u]),b.buffer(["propagate",p,l,"executor-err","resolve"+s]),C.buffer([u,"no-"+u]),P.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"]),a(T,m+s),a(T,m+"-done"),a(P,"new-jsonp"),a(P,"jsonp-end"),a(P,"cb-start"),E.on("pushState-end",i),E.on("replaceState-end",i),w[v]("hashchange",i,N(!0)),w[v]("load",i,N(!0)),w[v]("popstate",function(){i(0,U>1)},N(!0))}},{}],5:[function(t,e,n){function r(){var t=new PerformanceObserver(function(t,e){var n=t.getEntries();s(v,[n])});try{t.observe({entryTypes:["resource"]})}catch(e){}}function o(t){if(s(v,[window.performance.getEntriesByType(w)]),window.performance["c"+p])try{window.performance[h](m,o,!1)}catch(t){}else try{window.performance[h]("webkit"+m,o,!1)}catch(t){}}function i(t){}if(window.performance&&window.performance.timing&&window.performance.getEntriesByType){var a=t("ee"),s=t("handle"),c=t(14),f=t(13),u=t(6),d=t(23),p="learResourceTimings",l="addEventListener",h="removeEventListener",m="resourcetimingbufferfull",v="bstResource",w="resource",g="-start",y="-end",x="fn"+g,b="fn"+y,E="bstTimer",R="pushState",O=t("loader");if(!O.disabled){O.features.stn=!0,t(9),"addEventListener"in window&&t(7);var T=NREUM.o.EV;a.on(x,function(t,e){var n=t[0];n instanceof T&&(this.bstStart=O.now())}),a.on(b,function(t,e){var n=t[0];n instanceof T&&s("bst",[n,e,this.bstStart,O.now()])}),c.on(x,function(t,e,n){this.bstStart=O.now(),this.bstType=n}),c.on(b,function(t,e){s(E,[e,this.bstStart,O.now(),this.bstType])}),f.on(x,function(){this.bstStart=O.now()}),f.on(b,function(t,e){s(E,[e,this.bstStart,O.now(),"requestAnimationFrame"])}),a.on(R+g,function(t){this.time=O.now(),this.startPath=location.pathname+location.hash}),a.on(R+y,function(t){s("bstHist",[location.pathname+location.hash,this.startPath,this.time])}),u()?(s(v,[window.performance.getEntriesByType("resource")]),r()):l in window.performance&&(window.performance["c"+p]?window.performance[l](m,o,d(!1)):window.performance[l]("webkit"+m,o,d(!1))),document[l]("scroll",i,d(!1)),document[l]("keypress",i,d(!1)),document[l]("click",i,d(!1))}}},{}],6:[function(t,e,n){e.exports=function(){return"PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver}},{}],7:[function(t,e,n){function r(t){for(var e=t;e&&!e.hasOwnProperty(u);)e=Object.getPrototypeOf(e);e&&o(e)}function o(t){s.inPlace(t,[u,d],"-",i)}function i(t,e){return t[1]}var a=t("ee").get("events"),s=t("wrap-function")(a,!0),c=t("gos"),f=XMLHttpRequest,u="addEventListener",d="removeEventListener";e.exports=a,"getPrototypeOf"in Object?(r(document),r(window),r(f.prototype)):f.prototype.hasOwnProperty(u)&&(o(window),o(f.prototype)),a.on(u+"-start",function(t,e){var n=t[1];if(null!==n&&("function"==typeof n||"object"==typeof n)){var r=c(n,"nr@wrapped",function(){function t(){if("function"==typeof n.handleEvent)return n.handleEvent.apply(n,arguments)}var e={object:t,"function":n}[typeof n];return e?s(e,"fn-",null,e.name||"anonymous"):n});this.wrapped=t[1]=r}}),a.on(d+"-start",function(t){t[1]=this.wrapped||t[1]})},{}],8:[function(t,e,n){function r(t,e,n){var r=t[e];"function"==typeof r&&(t[e]=function(){var t=i(arguments),e={};o.emit(n+"before-start",[t],e);var a;e[m]&&e[m].dt&&(a=e[m].dt);var s=r.apply(this,t);return o.emit(n+"start",[t,a],s),s.then(function(t){return o.emit(n+"end",[null,t],s),t},function(t){throw o.emit(n+"end",[t],s),t})})}var o=t("ee").get("fetch"),i=t(32),a=t(31);e.exports=o;var s=window,c="fetch-",f=c+"body-",u=["arrayBuffer","blob","json","text","formData"],d=s.Request,p=s.Response,l=s.fetch,h="prototype",m="nr@context";d&&p&&l&&(a(u,function(t,e){r(d[h],e,f),r(p[h],e,f)}),r(s,"fetch",c),o.on(c+"end",function(t,e){var n=this;if(e){var r=e.headers.get("content-length");null!==r&&(n.rxSize=r),o.emit(c+"done",[null,e],n)}else o.emit(c+"done",[t],n)}))},{}],9:[function(t,e,n){var r=t("ee").get("history"),o=t("wrap-function")(r);e.exports=r;var i=window.history&&window.history.constructor&&window.history.constructor.prototype,a=window.history;i&&i.pushState&&i.replaceState&&(a=i),o.inPlace(a,["pushState","replaceState"],"-")},{}],10:[function(t,e,n){function r(t){function e(){f.emit("jsonp-end",[],l),t.removeEventListener("load",e,c(!1)),t.removeEventListener("error",n,c(!1))}function n(){f.emit("jsonp-error",[],l),f.emit("jsonp-end",[],l),t.removeEventListener("load",e,c(!1)),t.removeEventListener("error",n,c(!1))}var r=t&&"string"==typeof t.nodeName&&"script"===t.nodeName.toLowerCase();if(r){var o="function"==typeof t.addEventListener;if(o){var a=i(t.src);if(a){var d=s(a),p="function"==typeof d.parent[d.key];if(p){var l={};u.inPlace(d.parent,[d.key],"cb-",l),t.addEventListener("load",e,c(!1)),t.addEventListener("error",n,c(!1)),f.emit("new-jsonp",[t.src],l)}}}}}function o(){return"addEventListener"in window}function i(t){var e=t.match(d);return e?e[1]:null}function a(t,e){var n=t.match(l),r=n[1],o=n[3];return o?a(o,e[r]):e[r]}function s(t){var e=t.match(p);return e&&e.length>=3?{key:e[2],parent:a(e[1],window)}:{key:t,parent:window}}var c=t(23),f=t("ee").get("jsonp"),u=t("wrap-function")(f);if(e.exports=f,o()){var d=/[?&](?:callback|cb)=([^&#]+)/,p=/(.*)\.([^.]+)/,l=/^(\w+)(\.|$)(.*)$/,h=["appendChild","insertBefore","replaceChild"];Node&&Node.prototype&&Node.prototype.appendChild?u.inPlace(Node.prototype,h,"dom-"):(u.inPlace(HTMLElement.prototype,h,"dom-"),u.inPlace(HTMLHeadElement.prototype,h,"dom-"),u.inPlace(HTMLBodyElement.prototype,h,"dom-")),f.on("dom-start",function(t){r(t[0])})}},{}],11:[function(t,e,n){var r=t("ee").get("mutation"),o=t("wrap-function")(r),i=NREUM.o.MO;e.exports=r,i&&(window.MutationObserver=function(t){return this instanceof i?new i(o(t,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype)},{}],12:[function(t,e,n){function r(t){var e=i.context(),n=s(t,"executor-",e,null,!1),r=new f(n);return i.context(r).getCtx=function(){return e},r}var o=t("wrap-function"),i=t("ee").get("promise"),a=t("ee").getOrSetContext,s=o(i),c=t(31),f=NREUM.o.PR;e.exports=i,f&&(window.Promise=r,["all","race"].forEach(function(t){var e=f[t];f[t]=function(n){function r(t){return function(){i.emit("propagate",[null,!o],a,!1,!1),o=o||!t}}var o=!1;c(n,function(e,n){Promise.resolve(n).then(r("all"===t),r(!1))});var a=e.apply(f,arguments),s=f.resolve(a);return s}}),["resolve","reject"].forEach(function(t){var e=f[t];f[t]=function(t){var n=e.apply(f,arguments);return t!==n&&i.emit("propagate",[t,!0],n,!1,!1),n}}),f.prototype["catch"]=function(t){return this.then(null,t)},f.prototype=Object.create(f.prototype,{constructor:{value:r}}),c(Object.getOwnPropertyNames(f),function(t,e){try{r[e]=f[e]}catch(n){}}),o.wrapInPlace(f.prototype,"then",function(t){return function(){var e=this,n=o.argsToArray.apply(this,arguments),r=a(e);r.promise=e,n[0]=s(n[0],"cb-",r,null,!1),n[1]=s(n[1],"cb-",r,null,!1);var c=t.apply(this,n);return r.nextPromise=c,i.emit("propagate",[e,!0],c,!1,!1),c}}),i.on("executor-start",function(t){t[0]=s(t[0],"resolve-",this,null,!1),t[1]=s(t[1],"resolve-",this,null,!1)}),i.on("executor-err",function(t,e,n){t[1](n)}),i.on("cb-end",function(t,e,n){i.emit("propagate",[n,!0],this.nextPromise,!1,!1)}),i.on("propagate",function(t,e,n){this.getCtx&&!e||(this.getCtx=function(){if(t instanceof Promise)var e=i.context(t);return e&&e.getCtx?e.getCtx():this})}),r.toString=function(){return""+f})},{}],13:[function(t,e,n){var r=t("ee").get("raf"),o=t("wrap-function")(r),i="equestAnimationFrame";e.exports=r,o.inPlace(window,["r"+i,"mozR"+i,"webkitR"+i,"msR"+i],"raf-"),r.on("raf-start",function(t){t[0]=o(t[0],"fn-")})},{}],14:[function(t,e,n){function r(t,e,n){t[0]=a(t[0],"fn-",null,n)}function o(t,e,n){this.method=n,this.timerDuration=isNaN(t[1])?0:+t[1],t[0]=a(t[0],"fn-",this,n)}var i=t("ee").get("timer"),a=t("wrap-function")(i),s="setTimeout",c="setInterval",f="clearTimeout",u="-start",d="-";e.exports=i,a.inPlace(window,[s,"setImmediate"],s+d),a.inPlace(window,[c],c+d),a.inPlace(window,[f,"clearImmediate"],f+d),i.on(c+u,r),i.on(s+u,o)},{}],15:[function(t,e,n){function r(t,e){d.inPlace(e,["onreadystatechange"],"fn-",s)}function o(){var t=this,e=u.context(t);t.readyState>3&&!e.resolved&&(e.resolved=!0,u.emit("xhr-resolved",[],t)),d.inPlace(t,y,"fn-",s)}function i(t){x.push(t),m&&(E?E.then(a):w?w(a):(R=-R,O.data=R))}function a(){for(var t=0;t<x.length;t++)r([],x[t]);x.length&&(x=[])}function s(t,e){return e}function c(t,e){for(var n in t)e[n]=t[n];return e}t(7);var f=t("ee"),u=f.get("xhr"),d=t("wrap-function")(u),p=t(23),l=NREUM.o,h=l.XHR,m=l.MO,v=l.PR,w=l.SI,g="readystatechange",y=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],x=[];e.exports=u;var b=window.XMLHttpRequest=function(t){var e=new h(t);try{u.emit("new-xhr",[e],e),e.addEventListener(g,o,p(!1))}catch(n){try{u.emit("internal-error",[n])}catch(r){}}return e};if(c(h,b),b.prototype=h.prototype,d.inPlace(b.prototype,["open","send"],"-xhr-",s),u.on("send-xhr-start",function(t,e){r(t,e),i(e)}),u.on("open-xhr-start",r),m){var E=v&&v.resolve();if(!w&&!v){var R=1,O=document.createTextNode(R);new m(a).observe(O,{characterData:!0})}}else f.on("fn-end",function(t){t[0]&&t[0].type===g||a()})},{}],16:[function(t,e,n){function r(t){if(!s(t))return null;var e=window.NREUM;if(!e.loader_config)return null;var n=(e.loader_config.accountID||"").toString()||null,r=(e.loader_config.agentID||"").toString()||null,f=(e.loader_config.trustKey||"").toString()||null;if(!n||!r)return null;var h=l.generateSpanId(),m=l.generateTraceId(),v=Date.now(),w={spanId:h,traceId:m,timestamp:v};return(t.sameOrigin||c(t)&&p())&&(w.traceContextParentHeader=o(h,m),w.traceContextStateHeader=i(h,v,n,r,f)),(t.sameOrigin&&!u()||!t.sameOrigin&&c(t)&&d())&&(w.newrelicHeader=a(h,m,v,n,r,f)),w}function o(t,e){return"00-"+e+"-"+t+"-01"}function i(t,e,n,r,o){var i=0,a="",s=1,c="",f="";return o+"@nr="+i+"-"+s+"-"+n+"-"+r+"-"+t+"-"+a+"-"+c+"-"+f+"-"+e}function a(t,e,n,r,o,i){var a="btoa"in window&&"function"==typeof window.btoa;if(!a)return null;var s={v:[0,1],d:{ty:"Browser",ac:r,ap:o,id:t,tr:e,ti:n}};return i&&r!==i&&(s.d.tk=i),btoa(JSON.stringify(s))}function s(t){return f()&&c(t)}function c(t){var e=!1,n={};if("init"in NREUM&&"distributed_tracing"in NREUM.init&&(n=NREUM.init.distributed_tracing),t.sameOrigin)e=!0;else if(n.allowed_origins instanceof Array)for(var r=0;r<n.allowed_origins.length;r++){var o=h(n.allowed_origins[r]);if(t.hostname===o.hostname&&t.protocol===o.protocol&&t.port===o.port){e=!0;break}}return e}function f(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.enabled}function u(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.exclude_newrelic_header}function d(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&NREUM.init.distributed_tracing.cors_use_newrelic_header!==!1}function p(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.cors_use_tracecontext_headers}var l=t(28),h=t(18);e.exports={generateTracePayload:r,shouldGenerateTrace:s}},{}],17:[function(t,e,n){function r(t){var e=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var r=0;r<p;r++)t.removeEventListener(d[r],this.listener,!1);return e.protocol&&"data"===e.protocol?void g("Ajax/DataUrl/Excluded"):void(e.aborted||(n.duration=a.now()-this.startTime,this.loadCaptureCalled||4!==t.readyState?null==e.status&&(e.status=0):i(this,t),n.cbTime=this.cbTime,s("xhr",[e,n,this.startTime,this.endTime,"xhr"],this)))}}function o(t,e){var n=c(e),r=t.params;r.hostname=n.hostname,r.port=n.port,r.protocol=n.protocol,r.host=n.hostname+":"+n.port,r.pathname=n.pathname,t.parsedOrigin=n,t.sameOrigin=n.sameOrigin}function i(t,e){t.params.status=e.status;var n=v(e,t.lastSize);if(n&&(t.metrics.rxSize=n),t.sameOrigin){var r=e.getResponseHeader("X-NewRelic-App-Data");r&&(t.params.cat=r.split(", ").pop())}t.loadCaptureCalled=!0}var a=t("loader");if(a.xhrWrappable&&!a.disabled){var s=t("handle"),c=t(18),f=t(16).generateTracePayload,u=t("ee"),d=["load","error","abort","timeout"],p=d.length,l=t("id"),h=t(24),m=t(22),v=t(19),w=t(23),g=t(25).recordSupportability,y=NREUM.o.REQ,x=window.XMLHttpRequest;a.features.xhr=!0,t(15),t(8),u.on("new-xhr",function(t){var e=this;e.totalCbs=0,e.called=0,e.cbTime=0,e.end=r,e.ended=!1,e.xhrGuids={},e.lastSize=null,e.loadCaptureCalled=!1,e.params=this.params||{},e.metrics=this.metrics||{},t.addEventListener("load",function(n){i(e,t)},w(!1)),h&&(h>34||h<10)||t.addEventListener("progress",function(t){e.lastSize=t.loaded},w(!1))}),u.on("open-xhr-start",function(t){this.params={method:t[0]},o(this,t[1]),this.metrics={}}),u.on("open-xhr-end",function(t,e){"loader_config"in NREUM&&"xpid"in NREUM.loader_config&&this.sameOrigin&&e.setRequestHeader("X-NewRelic-ID",NREUM.loader_config.xpid);var n=f(this.parsedOrigin);if(n){var r=!1;n.newrelicHeader&&(e.setRequestHeader("newrelic",n.newrelicHeader),r=!0),n.traceContextParentHeader&&(e.setRequestHeader("traceparent",n.traceContextParentHeader),n.traceContextStateHeader&&e.setRequestHeader("tracestate",n.traceContextStateHeader),r=!0),r&&(this.dt=n)}}),u.on("send-xhr-start",function(t,e){var n=this.metrics,r=t[0],o=this;if(n&&r){var i=m(r);i&&(n.txSize=i)}this.startTime=a.now(),this.listener=function(t){try{"abort"!==t.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==t.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof e.onload))&&o.end(e)}catch(n){try{u.emit("internal-error",[n])}catch(r){}}};for(var s=0;s<p;s++)e.addEventListener(d[s],this.listener,w(!1))}),u.on("xhr-cb-time",function(t,e,n){this.cbTime+=t,e?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof n.onload||this.end(n)}),u.on("xhr-load-added",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&!this.xhrGuids[n]&&(this.xhrGuids[n]=!0,this.totalCbs+=1)}),u.on("xhr-load-removed",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&this.xhrGuids[n]&&(delete this.xhrGuids[n],this.totalCbs-=1)}),u.on("xhr-resolved",function(){this.endTime=a.now()}),u.on("addEventListener-end",function(t,e){e instanceof x&&"load"===t[0]&&u.emit("xhr-load-added",[t[1],t[2]],e)}),u.on("removeEventListener-end",function(t,e){e instanceof x&&"load"===t[0]&&u.emit("xhr-load-removed",[t[1],t[2]],e)}),u.on("fn-start",function(t,e,n){e instanceof x&&("onload"===n&&(this.onload=!0),("load"===(t[0]&&t[0].type)||this.onload)&&(this.xhrCbStart=a.now()))}),u.on("fn-end",function(t,e){this.xhrCbStart&&u.emit("xhr-cb-time",[a.now()-this.xhrCbStart,this.onload,e],e)}),u.on("fetch-before-start",function(t){function e(t,e){var n=!1;return e.newrelicHeader&&(t.set("newrelic",e.newrelicHeader),n=!0),e.traceContextParentHeader&&(t.set("traceparent",e.traceContextParentHeader),e.traceContextStateHeader&&t.set("tracestate",e.traceContextStateHeader),n=!0),n}var n,r=t[1]||{};"string"==typeof t[0]?n=t[0]:t[0]&&t[0].url?n=t[0].url:window.URL&&t[0]&&t[0]instanceof URL&&(n=t[0].href),n&&(this.parsedOrigin=c(n),this.sameOrigin=this.parsedOrigin.sameOrigin);var o=f(this.parsedOrigin);if(o&&(o.newrelicHeader||o.traceContextParentHeader))if("string"==typeof t[0]||window.URL&&t[0]&&t[0]instanceof URL){var i={};for(var a in r)i[a]=r[a];i.headers=new Headers(r.headers||{}),e(i.headers,o)&&(this.dt=o),t.length>1?t[1]=i:t.push(i)}else t[0]&&t[0].headers&&e(t[0].headers,o)&&(this.dt=o)}),u.on("fetch-start",function(t,e){this.params={},this.metrics={},this.startTime=a.now(),this.dt=e,t.length>=1&&(this.target=t[0]),t.length>=2&&(this.opts=t[1]);var n,r=this.opts||{},i=this.target;if("string"==typeof i?n=i:"object"==typeof i&&i instanceof y?n=i.url:window.URL&&"object"==typeof i&&i instanceof URL&&(n=i.href),o(this,n),"data"!==this.params.protocol){var s=(""+(i&&i instanceof y&&i.method||r.method||"GET")).toUpperCase();this.params.method=s,this.txSize=m(r.body)||0}}),u.on("fetch-done",function(t,e){if(this.endTime=a.now(),this.params||(this.params={}),"data"===this.params.protocol)return void g("Ajax/DataUrl/Excluded");this.params.status=e?e.status:0;var n;"string"==typeof this.rxSize&&this.rxSize.length>0&&(n=+this.rxSize);var r={txSize:this.txSize,rxSize:n,duration:a.now()-this.startTime};s("xhr",[this.params,r,this.startTime,this.endTime,"fetch"],this)})}},{}],18:[function(t,e,n){var r={};e.exports=function(t){if(t in r)return r[t];if(0===(t||"").indexOf("data:"))return{protocol:"data"};var e=document.createElement("a"),n=window.location,o={};e.href=t,o.port=e.port;var i=e.href.split("://");!o.port&&i[1]&&(o.port=i[1].split("/")[0].split("@").pop().split(":")[1]),o.port&&"0"!==o.port||(o.port="https"===i[0]?"443":"80"),o.hostname=e.hostname||n.hostname,o.pathname=e.pathname,o.protocol=i[0],"/"!==o.pathname.charAt(0)&&(o.pathname="/"+o.pathname);var a=!e.protocol||":"===e.protocol||e.protocol===n.protocol,s=e.hostname===document.domain&&e.port===n.port;return o.sameOrigin=a&&(!e.hostname||s),"/"===o.pathname&&(r[t]=o),o}},{}],19:[function(t,e,n){function r(t,e){var n=t.responseType;return"json"===n&&null!==e?e:"arraybuffer"===n||"blob"===n||"json"===n?o(t.response):"text"===n||""===n||void 0===n?o(t.responseText):void 0}var o=t(22);e.exports=r},{}],20:[function(t,e,n){function r(){}function o(t,e,n,r){return function(){return u.recordSupportability("API/"+e+"/called"),i(t+e,[f.now()].concat(s(arguments)),n?null:this,r),n?void 0:this}}var i=t("handle"),a=t(31),s=t(32),c=t("ee").get("tracer"),f=t("loader"),u=t(25),d=NREUM;"undefined"==typeof window.newrelic&&(newrelic=d);var p=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],l="api-",h=l+"ixn-";a(p,function(t,e){d[e]=o(l,e,!0,"api")}),d.addPageAction=o(l,"addPageAction",!0),d.setCurrentRouteName=o(l,"routeName",!0),e.exports=newrelic,d.interaction=function(){return(new r).get()};var m=r.prototype={createTracer:function(t,e){var n={},r=this,o="function"==typeof e;return i(h+"tracer",[f.now(),t,n],r),function(){if(c.emit((o?"":"no-")+"fn-start",[f.now(),r,o],n),o)try{return e.apply(this,arguments)}catch(t){throw c.emit("fn-err",[arguments,this,t],n),t}finally{c.emit("fn-end",[f.now()],n)}}}};a("actionText,setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(t,e){m[e]=o(h,e)}),newrelic.noticeError=function(t,e){"string"==typeof t&&(t=new Error(t)),u.recordSupportability("API/noticeError/called"),i("err",[t,f.now(),!1,e])}},{}],21:[function(t,e,n){function r(t){if(NREUM.init){for(var e=NREUM.init,n=t.split("."),r=0;r<n.length-1;r++)if(e=e[n[r]],"object"!=typeof e)return;return e=e[n[n.length-1]]}}e.exports={getConfiguration:r}},{}],22:[function(t,e,n){e.exports=function(t){if("string"==typeof t&&t.length)return t.length;if("object"==typeof t){if("undefined"!=typeof ArrayBuffer&&t instanceof ArrayBuffer&&t.byteLength)return t.byteLength;if("undefined"!=typeof Blob&&t instanceof Blob&&t.size)return t.size;if(!("undefined"!=typeof FormData&&t instanceof FormData))try{return JSON.stringify(t).length}catch(e){return}}}},{}],23:[function(t,e,n){var r=!1;try{var o=Object.defineProperty({},"passive",{get:function(){r=!0}});window.addEventListener("testPassive",null,o),window.removeEventListener("testPassive",null,o)}catch(i){}e.exports=function(t){return r?{passive:!0,capture:!!t}:!!t}},{}],24:[function(t,e,n){var r=0,o=navigator.userAgent.match(/Firefox[\/\s](\d+\.\d+)/);o&&(r=+o[1]),e.exports=r},{}],25:[function(t,e,n){function r(t,e){var n=[a,t,{name:t},e];return i("storeMetric",n,null,"api"),n}function o(t,e){var n=[s,t,{name:t},e];return i("storeEventMetrics",n,null,"api"),n}var i=t("handle"),a="sm",s="cm";e.exports={constants:{SUPPORTABILITY_METRIC:a,CUSTOM_METRIC:s},recordSupportability:r,recordCustom:o}},{}],26:[function(t,e,n){function r(){return s.exists&&performance.now?Math.round(performance.now()):(i=Math.max((new Date).getTime(),i))-a}function o(){return i}var i=(new Date).getTime(),a=i,s=t(33);e.exports=r,e.exports.offset=a,e.exports.getLastTimestamp=o},{}],27:[function(t,e,n){function r(t,e){var n=t.getEntries();n.forEach(function(t){"first-paint"===t.name?l("timing",["fp",Math.floor(t.startTime)]):"first-contentful-paint"===t.name&&l("timing",["fcp",Math.floor(t.startTime)])})}function o(t,e){var n=t.getEntries();if(n.length>0){var r=n[n.length-1];if(f&&f<r.startTime)return;var o=[r],i=a({});i&&o.push(i),l("lcp",o)}}function i(t){t.getEntries().forEach(function(t){t.hadRecentInput||l("cls",[t])})}function a(t){var e=navigator.connection||navigator.mozConnection||navigator.webkitConnection;if(e)return e.type&&(t["net-type"]=e.type),e.effectiveType&&(t["net-etype"]=e.effectiveType),e.rtt&&(t["net-rtt"]=e.rtt),e.downlink&&(t["net-dlink"]=e.downlink),t}function s(t){if(t instanceof w&&!y){var e=Math.round(t.timeStamp),n={type:t.type};a(n),e<=h.now()?n.fid=h.now()-e:e>h.offset&&e<=Date.now()?(e-=h.offset,n.fid=h.now()-e):e=h.now(),y=!0,l("timing",["fi",e,n])}}function c(t){"hidden"===t&&(f=h.now(),l("pageHide",[f]))}if(!("init"in NREUM&&"page_view_timing"in NREUM.init&&"enabled"in NREUM.init.page_view_timing&&NREUM.init.page_view_timing.enabled===!1)){var f,u,d,p,l=t("handle"),h=t("loader"),m=t(30),v=t(23),w=NREUM.o.EV;if("PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver){u=new PerformanceObserver(r);try{u.observe({entryTypes:["paint"]})}catch(g){}d=new PerformanceObserver(o);try{d.observe({entryTypes:["largest-contentful-paint"]})}catch(g){}p=new PerformanceObserver(i);try{p.observe({type:"layout-shift",buffered:!0})}catch(g){}}if("addEventListener"in document){var y=!1,x=["click","keydown","mousedown","pointerdown","touchstart"];x.forEach(function(t){document.addEventListener(t,s,v(!1))})}m(c)}},{}],28:[function(t,e,n){function r(){function t(){return e?15&e[n++]:16*Math.random()|0}var e=null,n=0,r=window.crypto||window.msCrypto;r&&r.getRandomValues&&(e=r.getRandomValues(new Uint8Array(31)));for(var o,i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx",a="",s=0;s<i.length;s++)o=i[s],"x"===o?a+=t().toString(16):"y"===o?(o=3&t()|8,a+=o.toString(16)):a+=o;return a}function o(){return a(16)}function i(){return a(32)}function a(t){function e(){return n?15&n[r++]:16*Math.random()|0}var n=null,r=0,o=window.crypto||window.msCrypto;o&&o.getRandomValues&&Uint8Array&&(n=o.getRandomValues(new Uint8Array(t)));for(var i=[],a=0;a<t;a++)i.push(e().toString(16));return i.join("")}e.exports={generateUuid:r,generateSpanId:o,generateTraceId:i}},{}],29:[function(t,e,n){function r(t,e){if(!o)return!1;if(t!==o)return!1;if(!e)return!0;if(!i)return!1;for(var n=i.split("."),r=e.split("."),a=0;a<r.length;a++)if(r[a]!==n[a])return!1;return!0}var o=null,i=null,a=/Version\/(\S+)\s+Safari/;if(navigator.userAgent){var s=navigator.userAgent,c=s.match(a);c&&s.indexOf("Chrome")===-1&&s.indexOf("Chromium")===-1&&(o="Safari",i=c[1])}e.exports={agent:o,version:i,match:r}},{}],30:[function(t,e,n){function r(t){function e(){t(s&&document[s]?document[s]:document[i]?"hidden":"visible")}"addEventListener"in document&&a&&document.addEventListener(a,e,o(!1))}var o=t(23);e.exports=r;var i,a,s;"undefined"!=typeof document.hidden?(i="hidden",a="visibilitychange",s="visibilityState"):"undefined"!=typeof document.msHidden?(i="msHidden",a="msvisibilitychange"):"undefined"!=typeof document.webkitHidden&&(i="webkitHidden",a="webkitvisibilitychange",s="webkitVisibilityState")},{}],31:[function(t,e,n){function r(t,e){var n=[],r="",i=0;for(r in t)o.call(t,r)&&(n[i]=e(r,t[r]),i+=1);return n}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],32:[function(t,e,n){function r(t,e,n){e||(e=0),"undefined"==typeof n&&(n=t?t.length:0);for(var r=-1,o=n-e||0,i=Array(o<0?0:o);++r<o;)i[r]=t[e+r];return i}e.exports=r},{}],33:[function(t,e,n){e.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(t,e,n){function r(){}function o(t){function e(t){return t&&t instanceof r?t:t?f(t,c,a):a()}function n(n,r,o,i,a){if(a!==!1&&(a=!0),!l.aborted||i){t&&a&&t(n,r,o);for(var s=e(o),c=m(n),f=c.length,u=0;u<f;u++)c[u].apply(s,r);var p=d[y[n]];return p&&p.push([x,n,r,s]),s}}function i(t,e){g[t]=m(t).concat(e)}function h(t,e){var n=g[t];if(n)for(var r=0;r<n.length;r++)n[r]===e&&n.splice(r,1)}function m(t){return g[t]||[]}function v(t){return p[t]=p[t]||o(n)}function w(t,e){l.aborted||u(t,function(t,n){e=e||"feature",y[n]=e,e in d||(d[e]=[])})}var g={},y={},x={on:i,addEventListener:i,removeEventListener:h,emit:n,get:v,listeners:m,context:e,buffer:w,abort:s,aborted:!1};return x}function i(t){return f(t,c,a)}function a(){return new r}function s(){(d.api||d.feature)&&(l.aborted=!0,d=l.backlog={})}var c="nr@context",f=t("gos"),u=t(31),d={},p={},l=e.exports=o();e.exports.getOrSetContext=i,l.backlog=d},{}],gos:[function(t,e,n){function r(t,e,n){if(o.call(t,e))return t[e];var r=n();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(t,e,{value:r,writable:!0,enumerable:!1}),r}catch(i){}return t[e]=r,r}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],handle:[function(t,e,n){function r(t,e,n,r){o.buffer([t],r),o.emit(t,e,n)}var o=t("ee").get("handle");e.exports=r,r.ee=o},{}],id:[function(t,e,n){function r(t){var e=typeof t;return!t||"object"!==e&&"function"!==e?-1:t===window?0:a(t,i,function(){return o++})}var o=1,i="nr@id",a=t("gos");e.exports=r},{}],loader:[function(t,e,n){function r(){if(!T++){var t=O.info=NREUM.info,e=m.getElementsByTagName("script")[0];if(setTimeout(f.abort,3e4),!(t&&t.licenseKey&&t.applicationID&&e))return f.abort();c(E,function(e,n){t[e]||(t[e]=n)});var n=a();s("mark",["onload",n+O.offset],null,"api"),s("timing",["load",n]);var r=m.createElement("script");0===t.agent.indexOf("http://")||0===t.agent.indexOf("https://")?r.src=t.agent:r.src=l+"://"+t.agent,e.parentNode.insertBefore(r,e)}}function o(){"complete"===m.readyState&&i()}function i(){s("mark",["domContent",a()+O.offset],null,"api")}var a=t(26),s=t("handle"),c=t(31),f=t("ee"),u=t(29),d=t(21),p=t(23),l=d.getConfiguration("ssl")===!1?"http":"https",h=window,m=h.document,v="addEventListener",w="attachEvent",g=h.XMLHttpRequest,y=g&&g.prototype,x=!1;NREUM.o={ST:setTimeout,SI:h.setImmediate,CT:clearTimeout,XHR:g,REQ:h.Request,EV:h.Event,PR:h.Promise,MO:h.MutationObserver};var b=""+location,E={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-spa-1216.min.js"},R=g&&y&&y[v]&&!/CriOS/.test(navigator.userAgent),O=e.exports={offset:a.getLastTimestamp(),now:a,origin:b,features:{},xhrWrappable:R,userAgent:u,disabled:x};if(!x){t(20),t(27),m[v]?(m[v]("DOMContentLoaded",i,p(!1)),h[v]("load",r,p(!1))):(m[w]("onreadystatechange",o),h[w]("onload",r)),s("mark",["firstbyte",a.getLastTimestamp()],null,"api");var T=0}},{}],"wrap-function":[function(t,e,n){function r(t,e){function n(e,n,r,c,f){function nrWrapper(){var i,a,u,p;try{a=this,i=d(arguments),u="function"==typeof r?r(i,a):r||{}}catch(l){o([l,"",[i,a,c],u],t)}s(n+"start",[i,a,c],u,f);try{return p=e.apply(a,i)}catch(h){throw s(n+"err",[i,a,h],u,f),h}finally{s(n+"end",[i,a,p],u,f)}}return a(e)?e:(n||(n=""),nrWrapper[p]=e,i(e,nrWrapper,t),nrWrapper)}function r(t,e,r,o,i){r||(r="");var s,c,f,u="-"===r.charAt(0);for(f=0;f<e.length;f++)c=e[f],s=t[c],a(s)||(t[c]=n(s,u?c+r:r,o,c,i))}function s(n,r,i,a){if(!h||e){var s=h;h=!0;try{t.emit(n,r,i,e,a)}catch(c){o([c,n,r,i],t)}h=s}}return t||(t=u),n.inPlace=r,n.flag=p,n}function o(t,e){e||(e=u);try{e.emit("internal-error",t)}catch(n){}}function i(t,e,n){if(Object.defineProperty&&Object.keys)try{var r=Object.keys(t);return r.forEach(function(n){Object.defineProperty(e,n,{get:function(){return t[n]},set:function(e){return t[n]=e,e}})}),e}catch(i){o([i],n)}for(var a in t)l.call(t,a)&&(e[a]=t[a]);return e}function a(t){return!(t&&t instanceof Function&&t.apply&&!t[p])}function s(t,e){var n=e(t);return n[p]=t,i(t,n,u),n}function c(t,e,n){var r=t[e];t[e]=s(r,n)}function f(){for(var t=arguments.length,e=new Array(t),n=0;n<t;++n)e[n]=arguments[n];return e}var u=t("ee"),d=t(32),p="nr@original",l=Object.prototype.hasOwnProperty,h=!1;e.exports=r,e.exports.wrapFunction=s,e.exports.wrapInPlace=c,e.exports.argsToArray=f},{}]},{},["loader",2,17,5,3,4]);</script><meta charset="UTF-8"/><meta name="robots" content="index, follow"/><meta name="DC.Creator" content="Seyyed Mojtaba Mousavi"/><meta name="DC.Creator" content="Foo Wah Low"/><meta name="DC.Creator" content="Seyyed Alireza Hashemi"/><meta name="DC.Creator" content="Nurul Asma Samsudin"/><meta name="DC.Creator" content="Mohammad Shakeri"/><meta name="DC.Creator" content="Yulisa Yusoff"/><meta name="DC.Creator" content="Mansoor Rahsepar"/><meta name="DC.Creator" content="Chin Wei Lai"/><meta name="DC.Creator" content="Aziz Babapoor"/><meta name="DC.Creator" content="Sadaf Soroshnia"/><meta name="DC.Creator" content="Su Mei Goh"/><meta name="DC.Creator" content="Sieh Kiong Tiong"/><meta name="DC.Creator" content="Nowshad Amin"/><meta name="DC.title" content="Development of hydrophobic reduced graphene oxide as a new efficient approach for photochemotherapy  "/><meta name="DC.publisher" content="Royal Society of Chemistry"/><meta name="DC.Date" content="2020/03/31"/><meta name="DC.Identifier" scheme="doi" content="10.1039/D0RA00186D"/><meta name="DC.Language" content="en"/><meta name="citation_title" content="Development of hydrophobic reduced graphene oxide as a new efficient approach for photochemotherapy  "/><meta name="citation_author" content="Seyyed Mojtaba Mousavi"/><meta name="citation_author" content="Foo Wah Low"/><meta name="citation_author" content="Seyyed Alireza Hashemi"/><meta name="citation_author" content="Nurul Asma Samsudin"/><meta name="citation_author" content="Mohammad Shakeri"/><meta name="citation_author" content="Yulisa Yusoff"/><meta name="citation_author" content="Mansoor Rahsepar"/><meta name="citation_author" content="Chin Wei Lai"/><meta name="citation_author" content="Aziz Babapoor"/><meta name="citation_author" content="Sadaf Soroshnia"/><meta name="citation_author" content="Su Mei Goh"/><meta name="citation_author" content="Sieh Kiong Tiong"/><meta name="citation_author" content="Nowshad Amin"/><meta name="citation_online_date" content="2020/03/31"/><meta name="citation_date" content="2020"/><meta name="citation_journal_title" content="RSC Advances"/><meta name="citation_volume" content="10"/><meta name="citation_issue" content="22"/><meta name="citation_firstpage" content="12851"/><meta name="citation_lastpage" content="12863"/><meta name="citation_doi" content="10.1039/D0RA00186D"/><meta name="citation_pdf_url" content="https://pubs.rsc.org/en/content/articlepdf/2020/ra/d0ra00186d"/><meta name="citation_abstract_html_url" content="https://pubs.rsc.org/en/content/articlelanding/2020/ra/d0ra00186d"/><meta name="citation_fulltext_html_url" content="https://pubs.rsc.org/en/content/articlehtml/2020/ra/d0ra00186d"/><link rel="shortcut icon" href=""/><link type="text/css" rel="stylesheet" href="/content/stylesheets/rschtml2.css?ver=6_2_1"/><link href="https://www.rsc-cdn.org/oxygen/assets/webfonts/fonts.min.css" rel="stylesheet" type="text/css"/><link type="text/css" rel="stylesheet" href="/content/stylesheets/pubs-ui.min.css"/><meta name="viewport" content="width=device-width, initial-scale=1"/><script type="text/javascript" src="/content/scripts/JQueryPlugins.min.js"> </script><script type="text/javascript" src="/content/scripts/GetAnchorText.js"> </script><script type="text/javascript">
    
      $(function() {
      $("table.tgroup tfoot th").attr("colspan", "100");
      $("table.tgroup.rtable").each( function (idx, el) {
      var tw = $(this).width();
      $(this).parent().css("min-width", tw+"px");
      });

      });
      
    </script><!--6_2_1--></head><body class="oxy-ui pubs-ui ahtml-page"><!--Google Tag Manager (noscript)--><noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-56FZ7G" height="0" width="0" style="display:none;visibility:hidden"> </iframe></noscript><!--End Google Tag Manager (noscript)--><div class="viewport autopad"><div class="pnl pnl--drop autopad"><span id="top"/><div id="wrapper"><div class="left_head"><a class="simple" href="/"><img class="rsc-logo" border="0" src="/content/NewImages/royal-society-of-chemistry-logo.png" alt="Royal Society of Chemistry"/></a><br/><span class="btnContainer"><a class="btn btn--tiny btn--primary" target="_blank" title="Link to PDF version" href="/en/content/articlepdf/2020/ra/d0ra00186d">View PDF Version</a></span><span class="btnContainer"><a class="btn btn--tiny btn--nobg" title="Link to previous article (id:d0ra01294g)" href="/en/content/articlehtml/2020/ra/d0ra01294g" target="_BLANK">Previous Article</a></span><span class="btnContainer"><a class="btn btn--tiny btn--nobg" title="Link to next article (id:d0ra00243g)" href="/en/content/articlehtml/2020/ra/d0ra00243g" target="_BLANK">Next Article</a></span></div><div class="right_head"><div id="crossmark_container"><div id="crossmark-content"><a id="open-crossmark" href="#" data-target="crossmark"><img style="max-width:100px" id="crossmark-logo" src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_square.svg" alt="Check for updates"/></a><script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"> </script></div></div><br/><span class="oa"><img src="/content/newimages/open_access_blue.png" alt=""/> Open Access Article<br/><img src="/content/newimages/CCBY-NC.svg" alt=""/>
This Open Access Article is licensed under a <a rel="license" href="http://creativecommons.org/licenses/by-nc/3.0/">Creative Commons Attribution-Non Commercial 3.0 Unported Licence</a></span></div><div class="article_info"> DOI: <a target="_blank" title="Link to landing page via DOI" href="https://doi.org/10.1039/D0RA00186D">10.1039/D0RA00186D</a>
(Review Article)
<span class="italic"><a title="Link to journal home page" href="https://doi.org/10.1039/2046-2069/2011">RSC Adv.</a></span>, 2020, <strong>10</strong>, 12851-12863</div><h1 id="sect231"><span class="title_heading">Development of hydrophobic reduced graphene oxide as a new efficient approach for photochemotherapy<a title="Select to navigate to footnote" href="#fn1">†</a></span></h1><p class="header_text">
<span class="bold">Seyyed Mojtaba Mousavi</span><sup><span class="sup_ref italic">a</span></sup>, 
<span class="bold">Foo Wah Low</span>*<sup><span class="sup_ref italic">b</span></sup>, 
<span class="bold">Seyyed Alireza Hashemi</span><sup><span class="sup_ref italic">c</span></sup>, 
<span class="bold">Nurul Asma Samsudin</span><sup><span class="sup_ref italic">b</span></sup>, 
<span class="bold">Mohammad Shakeri</span><sup><span class="sup_ref italic">b</span></sup>, 
<span class="bold">Yulisa Yusoff</span><sup><span class="sup_ref italic">b</span></sup>, 
<span class="bold">Mansoor Rahsepar</span><sup><span class="sup_ref italic">d</span></sup>, 
<span class="bold">Chin Wei Lai</span><span class="orcid"><a target="_blank" title="Select to open ORCID record for Chin Wei Lai (orcid.org/0000-0002-7549-5015) in a new window" id="connect-orcid-link" href="http://orcid.org/0000-0002-7549-5015"><img id="orcid-id-logo" src="/content/NewImages/orcid_16x16.png" alt="ORCID logo"/></a></span>*<sup><span class="sup_ref italic">e</span></sup>, 
<span class="bold">Aziz Babapoor</span><sup><span class="sup_ref italic">f</span></sup>, 
<span class="bold">Sadaf Soroshnia</span><sup><span class="sup_ref italic">f</span></sup>, 
<span class="bold">Su Mei Goh</span><sup><span class="sup_ref italic">f</span></sup>, 
<span class="bold">Sieh Kiong Tiong</span><sup><span class="sup_ref italic">g</span></sup><span class="bold"> and </span>
<span class="bold">Nowshad Amin</span><sup><span class="sup_ref italic">b</span></sup>
<br/><a id="affa"><sup><span class="sup_ref italic">a</span></sup></a><span class="italic">Department of Chemical Engineering, National Taiwan University of Science and Technology, Taiwan</span>
<br/><a id="affb"><sup><span class="sup_ref italic">b</span></sup></a><span class="italic">Institute of Sustainable Energy, Universiti Tenaga Nasional (@The Energy University), Jalan IKRAM-UNITEN, 43000 Kajang, Selangor, Malaysia. E-mail: <a href="mailto:lowfw@uniten.edu.my">lowfw@uniten.edu.my</a></span>
<br/><a id="affc"><sup><span class="sup_ref italic">c</span></sup></a><span class="italic">Department of Mechanical Engineering, Center for Nanofibers and Nanotechnology, National University of Singapore, Singapore</span>
<br/><a id="affd"><sup><span class="sup_ref italic">d</span></sup></a><span class="italic">Department of Materials Science and Engineering, School of Engineering, Shiraz University, Shiraz, Iran</span>
<br/><a id="affe"><sup><span class="sup_ref italic">e</span></sup></a><span class="italic">Nanotechnology &amp; Catalysis Research Centre, Level 3, Block A, Institute for Advanced Studies Building, University of Malaya, 50603 Kuala Lumpur, Malaysia. E-mail: <a href="mailto:cwlai@um.edu.my">cwlai@um.edu.my</a></span>
<br/><a id="afff"><sup><span class="sup_ref italic">f</span></sup></a><span class="italic">Department of Chemical Engineering, University of Mohaghegh Ardabili (UMA), Ardabil, Iran</span>
<br/><a id="affg"><sup><span class="sup_ref italic">g</span></sup></a><span class="italic">College of Engineering, Universiti Tenaga Nasional (@The Energy University), Jalan IKRAM-UNITEN, 43000 Kajang, Selangor, Malaysia</span>
</p><div id="art-admin"><span class="italic bold">Received 
8th January 2020
</span><span class="bold italic">, Accepted 9th March 2020</span></div><p class="bold italic">First published on 31st March 2020</p><hr/><div class="abstract"><h2>Abstract</h2><p>Nowadays, chemotherapy is one of the crucial and common therapies in the world. So far, it has been revealed to be highly promising, yet patients suffer from the consequences of severe negative medical dosages. In order to overcome these issues, the enhancement of photothermal chemotherapy with reduced graphene oxide (rGO) as a photothermal agent (PTA) is widely utilised in current medical technologies. This is due to its high near-infrared region (NIR) response, <span class="italic">in vitro</span> or <span class="italic">in vivo</span> organism biocompatibility, low risk of side effects, and effective positive results. Moreover, rGO not only has the ability to ensure that selective cancer cells have a higher mortality rate but can also improve the growth rate of recovering tissues that are untouched by necrosis and apoptosis. These two pathways are specific diverse modalities of cell death that are distinguished by cell membrane disruption and deoxyribonucleic acid (DNA) disintegration of the membrane <span class="italic">via</span> phosphatidylserine exposure in the absence of cell membrane damage. Therefore, this review aimed to demonstrate the recent achievements in the modification of rGO nanoparticles as a PTA as well as present a new approach for performing photochemotherapy in the clinical setting.</p></div><hr/>
<h2 id="sect374"><span class="a_heading">1. Introduction</span></h2>
<span>According to the World Health Organisation (WHO) data regarding the burden of cancer, an estimated 9.6 million deaths (ratio of 1<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>8 for men and 1<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>11 for women) were recorded in 2018 worldwide. Photothermal therapy (PTT) is a form of nanotechnology and it is noted as the most significant therapeutic method in utilising heat and having strong absorption in the near-infrared (NIR) region for cancer ablation purposes.<a title="Select to navigate to references" href="#cit1"><sup><span class="sup_ref">1</span></sup></a> Researchers have demonstrated the efficacy of many PTT agents in destroying cancer cells, such as the use of carbon nanomaterials as a theragnostic agent. However, laser irradiation in high doses can dramatically destroy the adjoining tissues. Besides, carbon nanomaterials coated with noble metal nanoparticles (gold and silver) are not biodegradable and may cause toxicity during treatment.</span>
<p class="otherpara">The development of nanoparticles with an abundance of purposes has been the subject of research and clinical field in recent decades. For cancer imaging and diagnosis, the usage of nanoparticles in either intrinsic biological factors of cancer or therapeutic functionalities are highly appreciated.<a title="Select to navigate to reference" href="#cit2"><sup><span class="sup_ref">2–10</span></sup></a> By adopting nanoparticle materials in therapies, some toxic chemicals (<span class="italic">e.g.</span>, dyes and drugs) can be easily eliminated in cancer diagnostics and treatments. Besides, fluorescent molecular dyes are potentially an incorrect option for medical purposes as they can cause various negative effects due to their inherent toxicity. Recently, nanoparticles with functionalised carbon family networks have shown great promise for cancer targeting and drug delivery in specific chemotherapy treatments, such as carbon dots, carbon nanotubes (CNTs), fullerenes, and graphene materials.<a title="Select to navigate to reference" href="#cit11"><sup><span class="sup_ref">11–16</span></sup></a> Among these carbon nanomaterials, graphene is the most suitable and commonly used material in a variety of applications due to its sheet flexibility. It is capable of generating heat by alternating the magnetic field or through lasers of noble metals.<a title="Select to navigate to reference" href="#cit17"><sup><span class="sup_ref">17,18</span></sup></a></p>
<p class="otherpara">Nowadays, different specific structures of graphene oxide (GO) have been numerously prepared <span class="italic">via</span> different ways and with different extents of oxidation. In general, strong photoluminescence can be produced from GO with either wave laser access, a pulsed laser (visible range), or NIR wavelength conditions; the outcome will be dye-free labelling cells for diagnostics. In fact, the concensus is that GO consists of many functionalised groups, whereby a majority of them comprise carboxylic and hydroxylic groups. This demonstrates their surface functionalisation role for numerous applications, such as drug delivery and biosensing.<a title="Select to navigate to reference" href="#cit19"><sup><span class="sup_ref">19,20</span></sup></a> Specifically, graphene is defined as a two-dimensional (2D) basal planar structure with a one-atom thickness of approximately 0.35–1.6 nm per layer. It shows a trigonal hybridisation of the carbon–carbon atom bonds, which are firmly arranged into a honeycomb crystal network.<a title="Select to navigate to references" href="#cit21"><sup><span class="sup_ref">21</span></sup></a> Moreover, graphene exhibits doubled larger surface area than CNTs, rendering it applicable as a drug carrier agent. In addition, the graphene material is highly recommended as a drug carrier agent due to its hydrophobic behaviour. Su <span class="italic">et al.</span> revealed that preparing it by a chemical reduction method can prevent its aggregation.<a title="Select to navigate to references" href="#cit22"><sup><span class="sup_ref">22</span></sup></a></p>
<p class="otherpara">Upon oxidation, the stacked graphene sheets of a carbonaceous structure will break up and generate flaws that are visible as clear stacked wrinkles, and which significantly increase the adjacent sheet distance from 3.35 Å to 6.8 Å for graphite and GO, respectively. The increased spacing is affected by its water intercalation and results in the delamination of GO into multiple individual GO sheets under low-power sonication in water. For pH measurement, negatively charged oxygenated functional groups on the GO surface will remain even though they are produced in an aqueous solution. Besides, it promises other outstanding properties, such as low production cost, a large surface area for drug absorption and low toxic metallic contaminations from the preparation process.<a title="Select to navigate to references" href="#cit23"><sup><span class="sup_ref">23</span></sup></a> In addition, GO and its composites have been shown to achieve a considerably improved tumour targeting effect and higher tumour uptake due to enhanced permeability and their retention effects compared to CNTs, which are assumed to be due to their special features of a 2D structure and thin lateral size.<a title="Select to navigate to reference" href="#cit24"><sup><span class="sup_ref">24–27</span></sup></a> Apart from this, reduced graphene oxide (rGO) embraces a unique structure, which shows strong interaction between the carbon–carbon interlayers and exhibits low energy photons in the infrared region (<span class="italic">i.e.</span> approaching X-rays and gamma rays).</p>
<p class="otherpara">Remarkably, graphene has shown the capability to give a good response under specific wavelengths, such as NIR, and demonstrates plasmonic effects, which means it can generate heat <span class="italic">via</span> the plasmonic photothermal energy conversion route. When irradiated under NIR, graphene surface plasmons will induce a random dipole, while its resonance will be transmitted, which can be used to tune the thermal photon energy to gain a better output. Therefore, graphene-based materials are known as excellent photothermal agents (PTAs) for PTT. For rGO, its photothermal conversion efficiency is derived by the chemical reduction from GO, namely with the partially reinstated aromatic character of the graphene sheets. Interestingly, its NIR absorbance can be improved by up to six times compared to GO due to its highly intact aromatic structure.<a title="Select to navigate to references" href="#cit28"><sup><span class="sup_ref">28</span></sup></a> Gonçalves and co-workers proved that an extremely small amount of nano-GO (<span class="italic">i.e.</span> 0.0005 mg mL<small><sup>−1</sup></small>) could transfer energy from particles to a specific solution <span class="italic">via</span> radiation (<span class="italic">i.e.</span> under irradiation at 980 nm laser with an intensity of 1.0 × 10<small><sup>5</sup></small> W m<small><sup>−2</sup></small>).<a title="Select to navigate to references" href="#cit29"><sup><span class="sup_ref">29</span></sup></a> In fact, rGO itself is rich of oxygenated atoms as it approaches the site of defect, it still raises from the coupling of electronic states against the asymmetric stretch mode and thus considerably improves the infrared absorption for PTT.<a title="Select to navigate to reference" href="#cit30"><sup><span class="sup_ref">30,31</span></sup></a></p>
<p class="otherpara">Commonly, cancer disease treatments <span class="italic">via</span> PTT facilities involving photosensitising agents utilise their own cells to produce heat from light absorption. Further harvesting for photoablation will result in both the living cancer cells and healthy cells being led to their death.<a title="Select to navigate to reference" href="#cit32"><sup><span class="sup_ref">32,33</span></sup></a> In order to prevent healthy cells from being heated, photosensitisers must be developed for high NIR absorption and for selective cancer-causing tumour cell death over healthy cells and tissues. The sharp penetration and minor nonspecific and non-uniform distribution of photothermal heating in the NIR window can result in lower light absorption by the tissues and in greater transparency within the optical window.<a title="Select to navigate to references" href="#cit34"><sup><span class="sup_ref">34</span></sup></a> In particular, novel materials with high optical absorbance in the NIR region for PTT include gold nanoshells,<a title="Select to navigate to references" href="#cit34"><sup><span class="sup_ref">34</span></sup></a> gold nanorods<a title="Select to navigate to reference" href="#cit35"><sup><span class="sup_ref">35,36</span></sup></a> and CNTs.<a title="Select to navigate to reference" href="#cit37"><sup><span class="sup_ref">37–39</span></sup></a> In <a title="Select to navigate to table" href="#tab1">Table 1</a>, the photothermal therapies utilising different materials and an 808 nm diode laser are demonstrated with the effective laser intensity of 0.7–9.2 W cm<small><sup>−2</sup></small>.</p>

<div class="table_caption"><b>Table 1</b> <span id="tab1">Summary of some photothermal cancer therapy-based graphene materials</span>
		</div>

<div class="rtable__wrapper"><div class="rtable__inner"><table class="tgroup rtable" border="0"><colgroup><col/><col/><col/><col/><col/><col/><col/><col/><col/></colgroup>









<thead align="left">
<tr align="left" valign="bottom">
<th align="left" valign="bottom" class="border_black">Nanoconjugates</th>
<th align="left" valign="bottom" class="border_black">Modified materials</th>
<th align="left" valign="bottom" class="border_black">Particle sizes (nm)</th>
<th align="left" valign="bottom" class="border_black">Laser</th>
<th align="left" valign="bottom" class="border_black">Power density (W cm<small><sup>−2</sup></small>)</th>
<th align="left" valign="bottom" class="border_black">Drug/imaging molecules used</th>
<th align="left" valign="bottom" class="border_black">Model</th>
<th align="left" valign="bottom" class="border_black">Performances</th>
<th align="left" valign="bottom" class="border_black">References</th>
</tr>
</thead>
<tbody align="left">
<tr align="left">
<td valign="top">Polydopamine functionalised reduced graphene oxide (pRGO) with hyaluronic acid (HA) coated mesoporous silica (MS) pRGO@MS-HA</td>
<td valign="top">MS-HA</td>
<td valign="top">∼200</td>
<td valign="top">808 nm NIR laser</td>
<td valign="top">1.5</td>
<td valign="top">Doxorubicin (DOX)</td>
<td valign="top"><span class="italic">In vitro</span> and <span class="italic">in vivo</span></td>
<td valign="top">Efficient synergistic targeted chemo-PTT, has minimal cytotoxicity. Good specificity to target tumour cells</td>
<td valign="top"><a title="Select to navigate to references" href="#cit40">40</a></td>
</tr>
<tr align="left">
<td valign="top">Alanine incorporated functionalised graphene oxide (ARGO)</td>
<td valign="top">Alanine</td>
<td valign="top">—</td>
<td valign="top">808 nm NIR laser</td>
<td valign="top">2.5</td>
<td valign="top">U87-MG</td>
<td valign="top"><span class="italic">In vitro</span></td>
<td valign="top">Functional groups allow more accurate targeting in PTT without damaging tissue and healthy cells</td>
<td valign="top"><a title="Select to navigate to references" href="#cit41">41</a></td>
</tr>
<tr align="left">
<td valign="top">Nano graphite oxide (nGO)</td>
<td valign="top">Gluthathione (GSH)</td>
<td valign="top">∼50</td>
<td valign="top">808 nm NIR laser</td>
<td valign="top">3.0</td>
<td valign="top">DOX</td>
<td valign="top"><span class="italic">In vitro</span></td>
<td valign="top">Higher cancer cell death efficacy</td>
<td valign="top"><a title="Select to navigate to references" href="#cit42">42</a></td>
</tr>
<tr align="left">
<td valign="top">Artesunate (ARS) modified PEGylated nanographene oxide (nGO-PEG), nGO-PEG-ARS</td>
<td valign="top">ARS</td>
<td valign="top">182</td>
<td valign="top">808 nm NIR laser</td>
<td valign="top">2.0</td>
<td valign="top">Reactive oxygen species (ROS) and peroxynitrite (ONOO)</td>
<td valign="top"><span class="italic">In vitro</span> and <span class="italic">in vivo</span></td>
<td valign="top">Faster tumour cure process</td>
<td valign="top"><a title="Select to navigate to references" href="#cit43">43</a></td>
</tr>
<tr align="left">
<td valign="top">rGO</td>
<td valign="top">rGO</td>
<td valign="top">∼100</td>
<td valign="top">980 nm laser</td>
<td valign="top">0.5–0.75</td>
<td valign="top">Panc02-H7</td>
<td valign="top"><span class="italic">In vivo</span></td>
<td valign="top">Enable obtaining the desired thermal destruction effect on mice pancreatic cancers</td>
<td valign="top"><a title="Select to navigate to references" href="#cit44">44</a></td>
</tr>
<tr align="left">
<td valign="top">rGO-hyaluronic acid (HA)-based amphiphilic polymer</td>
<td valign="top">Amphiphile</td>
<td valign="top">108 ± 51</td>
<td valign="top">808 nm NIR light</td>
<td valign="top">1.7</td>
<td valign="top">CD44</td>
<td valign="top"><span class="italic">In vitro</span></td>
<td valign="top">Induced cancer cell's ablation</td>
<td valign="top"><a title="Select to navigate to references" href="#cit45">45</a></td>
</tr>
<tr align="left">
<td valign="top">Polyethylene glycol functionalised rGO with gold (Au) nanorods Au NRs@rGO-PEG</td>
<td valign="top">Au nanorods</td>
<td valign="top">∼100</td>
<td valign="top">800 nm</td>
<td valign="top">0.7</td>
<td valign="top">Glioblastoma astrocytoma (U87MG)</td>
<td valign="top"><span class="italic">In vitro</span> and <span class="italic">in vivo</span></td>
<td valign="top">Significant drop in tumour size after 5 days</td>
<td valign="top"><a title="Select to navigate to references" href="#cit46">46</a></td>
</tr>
<tr align="left">
<td valign="top">Nanographene oxide methylene blue platform (NanoGO-MB)</td>
<td valign="top">MB</td>
<td valign="top">&gt;100</td>
<td valign="top">808 nm NIR laser</td>
<td valign="top">9.2</td>
<td valign="top">NIH/3T3 and 4T1</td>
<td valign="top"><span class="italic">In vitro</span> and <span class="italic">in vivo</span></td>
<td valign="top">All tumours defeated once PDT/PTT were combined</td>
<td valign="top"><a title="Select to navigate to references" href="#cit47">47</a></td>
</tr>
<tr align="left">
<td valign="top">Immobilised antiarrhythmic peptide 10 (APP10) decorated with dopamine-modified rGO (AAP10-pDA/rGO)</td>
<td valign="top">AAP10</td>
<td valign="top">∼300</td>
<td valign="top">808 nm NIR laser</td>
<td valign="top">1.5</td>
<td valign="top">MCF-10A, MCF-7, and 4T1</td>
<td valign="top"><span class="italic">In vitro</span> and <span class="italic">in vivo</span></td>
<td valign="top">Improved the therapeutic efficiency against the bystander effect</td>
<td valign="top"><a title="Select to navigate to references" href="#cit48">48</a></td>
</tr>
</tbody>
</table></div></div>
<hr class="hrule"/><br/>
<p class="otherpara">This paper reviews the recent developments of metabolic imaging systems for photochemotherapy using 2D carbon materials of graphene and graphene-based conjugates for cancer disease healing purposes. Briefly, the graphene strategies are summarised into three main sections: (i) rGO preparation methods, (ii) photothermal chemotherapy applications and (iii) future perspective of PTT using rGO. Furthermore, the future perspective of PTT <span class="italic">via</span> graphene strategies for drug carrier anticancer treatment is described accordingly. This work addresses the use of graphene nanomaterials in a biomedical perspective for bioimaging and theranostic tools over the last couple of years (<a title="Select to navigate to table" href="#tab1">Table 1</a>). In this comprehensive work, the promising approaches, limitations and challenges in the field of cancer treatment are assessed <span class="italic">via</span> graphene-incorporated imaging tools/drugs delivery.</p>

<h2 id="sect557"><span class="a_heading">2. Reduced graphene oxide preparation methods</span></h2>
<span>Generally, rGO is produced from GO or exfoliated graphite oxide <span class="italic">via</span> chemical or thermal reductive approaches. Some of the specific surface areas and capacitors that thermally and chemically reduce GO are summarised and listed in <a title="Select to navigate to table" href="#tab2">Table 2</a>. From the short description, rGO is defined as an intermediate structure between ideal graphene and partially oxidised GO.<a title="Select to navigate to references" href="#cit49"><sup><span class="sup_ref">49</span></sup></a> It is not only applicable to the biomedical field but also in other fields. Further physicochemical properties of the materials containing GO are listed in <a title="Select to navigate to figure" href="#imgfig1">Fig. 1</a> and <a title="Select to navigate to table" href="#tab3">Table 3</a>.</span>

<div class="table_caption"><b>Table 2</b> <span id="tab2">Chemical and thermal production of graphene</span>
		</div>

<div class="rtable__wrapper"><div class="rtable__inner"><table class="tgroup rtable" border="0"><colgroup><col/><col/><col/><col/><col/><col/><col/></colgroup>







<thead align="left">
<tr align="left" valign="bottom">
<th align="left" valign="bottom" class="border_black">Type of graphene</th>
<th align="left" valign="bottom" class="border_black">Reinforced materials</th>
<th align="left" valign="bottom" class="border_black">Methods</th>
<th align="left" valign="bottom" class="border_black">Size obtained (nm)</th>
<th align="left" valign="bottom" class="border_black">Conductivity (S m<small><sup>−1</sup></small>)</th>
<th align="left" valign="bottom" class="border_black">Application</th>
<th align="left" valign="bottom" class="border_black">Ref.</th>
</tr>
</thead>
<tbody align="left">
<tr align="left">
<td valign="top">rGO</td>
<td valign="top">Epoxy resin polymer</td>
<td valign="top">Chemical</td>
<td valign="top">60</td>
<td valign="top">—</td>
<td valign="top">Electromagnetic interference shielding and microwave-absorbing</td>
<td valign="top"><a title="Select to navigate to references" href="#cit50">50</a></td>
</tr>
<tr align="left">
<td valign="top">rGO</td>
<td valign="top"><span class="small_caps">L</span>-Ascorbic acid</td>
<td valign="top">Chemical and mechanical</td>
<td valign="top">24.49</td>
<td valign="top">7640</td>
<td valign="top">—</td>
<td valign="top"><a title="Select to navigate to references" href="#cit51">51</a></td>
</tr>
<tr align="left">
<td valign="top">rGO</td>
<td valign="top">Titanium dioxide</td>
<td valign="top">Chemical</td>
<td valign="top">47</td>
<td valign="top">11.2 μ</td>
<td valign="top">Dye-sensitised solar cells</td>
<td valign="top"><a title="Select to navigate to reference" href="#cit52">52–55</a></td>
</tr>
<tr align="left">
<td valign="top">rGO</td>
<td valign="top">Glassy carbon</td>
<td valign="top">Chemical</td>
<td valign="top">—</td>
<td valign="top">—</td>
<td valign="top">Neurotransmitter</td>
<td valign="top"><a title="Select to navigate to references" href="#cit56">56</a></td>
</tr>
<tr align="left">
<td valign="top">rGO</td>
<td valign="top">Titanium dioxide</td>
<td valign="top">Mechanical</td>
<td valign="top">25</td>
<td valign="top">—</td>
<td valign="top">Fibre-shaped dye-sensitised solar cells</td>
<td valign="top"><a title="Select to navigate to references" href="#cit57">57</a></td>
</tr>
<tr align="left">
<td valign="top">rGO</td>
<td valign="top">—</td>
<td valign="top">Mechanical</td>
<td valign="top">84.1</td>
<td valign="top">—</td>
<td valign="top">Neural repair</td>
<td valign="top"><a title="Select to navigate to references" href="#cit58">58</a></td>
</tr>
</tbody>
</table></div></div>
<hr class="hrule"/><br/>
<br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig1"><a href="/image/article/2020/RA/d0ra00186d/d0ra00186d-f1_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d0ra00186d-f1.tif" src="/image/article/2020/RA/d0ra00186d/d0ra00186d-f1.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 1 </b> <span id="fig1"><span class="graphic_title">(a) Schematic diagram of a highly oxidised rGO sheet, (b) photograph of aqueous solutions of graphene sheets reduced in the absence (left) and presence (right) of poly(sodium4-styrenesulfonate) (PSS),<a title="Select to navigate to references" href="#cit59"><sup><span class="sup_ref">59</span></sup></a> (c) image of a graphene sheet,<a title="Select to navigate to references" href="#cit60"><sup><span class="sup_ref">60</span></sup></a> (d) cross-sectional view of graphene paper layered structure,<a title="Select to navigate to references" href="#cit61"><sup><span class="sup_ref">61</span></sup></a> (e) morphological view of aggregated graphene sheets in the form of graphene powder,<a title="Select to navigate to references" href="#cit62"><sup><span class="sup_ref">62</span></sup></a> (f) transparent conductive graphene thin film fabricated <span class="italic">via</span> Langmuir–Blodgett assembly with plot results.<a title="Select to navigate to references" href="#cit63"><sup><span class="sup_ref">63</span></sup></a></span></span></td><td class="pushTitleLeft"> </td></tr></table></div>

<div class="table_caption"><b>Table 3</b> <span id="tab3">Physicochemical properties of various types of graphene</span>
		</div>

<div class="rtable__wrapper"><div class="rtable__inner"><table class="tgroup rtable" border="0"><colgroup><col/><col/><col/><col/></colgroup>




<thead align="left">
<tr align="left" valign="bottom">
<th align="left" valign="bottom" class="border_black">Properties</th>
<th align="left" valign="bottom" class="border_black">Monolayer graphene</th>
<th align="left" valign="bottom" class="border_black">GO</th>
<th align="left" valign="bottom" class="border_black">rGO</th>
</tr>
</thead>
<tbody align="left">
<tr align="left">
<td valign="top">Young's modulus</td>
<td valign="top">1 TPa</td>
<td valign="top">207.6 GPa</td>
<td valign="top">—</td>
</tr>
<tr align="left">
<td valign="top">Tensile strength</td>
<td valign="top">130 GPa</td>
<td valign="top">37.9 MPa</td>
<td valign="top">—</td>
</tr>
<tr align="left">
<td valign="top">Optical transmittance</td>
<td valign="top">97.7%</td>
<td valign="top">24.8%</td>
<td valign="top">(60–90% depending on the reduction agent and synthesis method)</td>
</tr>
<tr align="left">
<td valign="top">Charge carrier density</td>
<td valign="top">8.7 × 10<small><sup>12</sup></small> cm<small><sup>−2</sup></small></td>
<td valign="top">—</td>
<td valign="top">—</td>
</tr>
<tr align="left">
<td valign="top">Charge mobility (ambient temperature)</td>
<td valign="top">200<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>000 cm<small><sup>2</sup></small> V<small><sup>−1</sup></small> s<small><sup>−1</sup></small></td>
<td valign="top">—</td>
<td valign="top">372 cm<small><sup>2</sup></small> V<small><sup>−1</sup></small> s<small><sup>−1</sup></small></td>
</tr>
<tr align="left">
<td valign="top">Thermal conductivity</td>
<td valign="top">2000–5000 W m K<small><sup>−1</sup></small></td>
<td valign="top">2000 W m K<small><sup>−1</sup></small> for uncontaminated 600 W m K<small><sup>−1</sup></small> on Si/SiO<small><sub>2</sub></small> substrate</td>
<td valign="top">8.8 W m K<small><sup>−1</sup></small></td>
</tr>
<tr align="left">
<td valign="top">Electrical conductivity</td>
<td valign="top">700 S cm<small><sup>−1</sup></small></td>
<td valign="top">&lt;1 μS cm<small><sup>−1</sup></small></td>
<td valign="top">200–35<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>000 S cm<small><sup>−1</sup></small></td>
</tr>
</tbody>
</table></div></div>
<hr class="hrule"/><br/>
<p class="otherpara">Previously, Becerril <span class="italic">et al.</span><a title="Select to navigate to references" href="#cit64"><sup><span class="sup_ref">64</span></sup></a> tried to reduce GO films at 1000 °C by using the thermal annealing method and discovered the ideal vacuum level was at &lt;10<small><sup>5</sup></small> Torr for GO recovery. At that particular moment, the film will rapidly disappear <span class="italic">via</span> a reaction with the residual oxygen throughout the system. Moreover, inert atmospheres are one of the essential factors of concern; for example, reducing hydrogen gas (H<small><sub>2</sub></small>) is typically provided to eliminate the residual oxygen. In addition, H<small><sub>2</sub></small> is especially used for its high reducing abilities for the reduction of GO, which can be achieved at a low temperature under a H<small><sub>2</sub></small> atmosphere. Furthermore, Wu <span class="italic">et al.</span> reported that GO was easily reduced under an Ar/H<small><sub>2</sub></small> mixture (1<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>1) access for 2 h at 450 °C with a C/O ratio of 14.9, ultimately achieving a conductivity of up to ∼1100 S cm<small><sup>−1</sup></small>. Besides, Li <span class="italic">et al.</span><a title="Select to navigate to references" href="#cit65"><sup><span class="sup_ref">65</span></sup></a> demonstrated that GO could be synthesised in low-pressure ammonia mixture (<span class="italic">i.e.</span> 2 Torr NH<small><sub>3</sub></small>/Ar (10% NH<small><sub>3</sub></small>)) <span class="italic">via</span> the thermal annealing technique. In other preparatory methods, GO can also be reduced through photochemical reactions with the assistance of an active metal oxide photocatalyst (<span class="italic">i.e.</span> titanium dioxide (TiO<small><sub>2</sub></small>)). Recently, Williams <span class="italic">et al.</span> demonstrated reducing GO <span class="italic">via</span> integrated TiO<small><sub>2</sub></small> particles under ultraviolet (UV) irradiation, whereby the indicator colour immediately changed from bright brown to dark brown and then to black.<a title="Select to navigate to references" href="#cit66"><sup><span class="sup_ref">66</span></sup></a> This tuned colour suggests the partial restoration of the conjugated network in the respective carbon basal planes, similar to with the chemical reduction processes.</p>
<p class="otherpara">Meanwhile, An and co-workers<a title="Select to navigate to references" href="#cit67"><sup><span class="sup_ref">67</span></sup></a> employed the electrophoretic deposition method (EPD) to produce GO films. During the EPD process, they aimed to reduce the GO sheets for the anode surface, which was counter-intuitive to the assumption that oxidation occurred at the anode as an electrolysis cell. Although the reduction reaction is yet to be fully discovered, assembling the films and simultaneously reducing them may be particularly attractive in some electrochemical applications. In another research, Dubin <span class="italic">et al.</span><a title="Select to navigate to references" href="#cit67"><sup><span class="sup_ref">67</span></sup></a> reported that the reduction of graphene while applying the <span class="italic">N</span>-methyl-2-pyrrolidinone (NMP) solvent as a modification may be done for the solvothermal approach. The method is totally different from the common synthesis route in which the reduction of graphene is performed in a non-sealed container. In addition, the samples were heated at the temperature of 200 °C, which was 2 °C lower than the actual boiling point of NMP (202 °C, 1 atm). In this comprehensive experiment, no further additional pressure was needed in the reduction process. The established deoxygenation of GO notes that the NMP solvent can be combined with its's moderate thermal annealing and oxygen-scavenging properties at high temperature. Nonetheless, the electrical conductivity performance and subsequent vacuum filtration of the rGO films was measured as 3.74 S cm<small><sup>−1</sup></small> for the solvothermal reduction method, which was exactly one order of magnitude smaller than for the hydrazine solvent reduction method (82.8 S cm<small><sup>−1</sup></small>). The carbon to oxygen (C<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>O) ratio <span class="italic">via</span> solvothermal-reduced GO was just 5.15, which was also inferior to other results. Thus, the solvothermal reduction method is considered a moderate reduction method for GO. Regardless, it has shown much more suitable results by creating a stable dispersion of rGO sheets, which is worthwhile for usable applications.</p>

<h2 id="sect748"><span class="a_heading">3. Photothermal chemotherapy and the biomedical applications of rGO</span></h2>
<span>rGO has been widely used for biomedical applications across a wide range over the past few years. For instance, photoresponsive indocyanine green-loaded GO nanosheets are known as a theranostic nanoplatform for photoacoustic imaging guiding and synergistic PTT treatments. They have the ability to enhance the PTT efficiency with cancer-targeting by increasing the photostability in the presence of folic acid (FA) conjugation for cancer therapies. Nevertheless, it has been revealed that fluorescent methods using organic dyes have several limitations, including dye degradation, photobleaching and a set limitation beyond clinical applications. To date, further <span class="italic">in vitro</span> imaging of NIH/3T3 cells has been tested under oleylamine-functionalised GO hybrid nanocomposites on zinc-doped AgInS quantum dots (QDs).<a title="Select to navigate to references" href="#cit68"><sup><span class="sup_ref">68</span></sup></a> The confocal imaging illustrated the accumulation of nanocomposites in the cytoplasm or protoplasm within a living cell, which were seen to be circulated around the nucleus. Nanocomposites QDs have displayed brighter fluorescence, lower photobleaching, a thinner photoluminescence spectra, and improved anticorrosion against chemical degradation. Besides, they have demonstrated a higher toxicity level without the therapeutic functions for biomedical applications.<a title="Select to navigate to references" href="#cit69"><sup><span class="sup_ref">69</span></sup></a> To overcome these issues, novel research has created QD-decorated rGO nanocomposites for fluorescent cell imaging and PTT.<a title="Select to navigate to references" href="#cit70"><sup><span class="sup_ref">70</span></sup></a> These nanocomposites have addressed several critical issues, such as QDs toxicity being reduced by surfactant coating and the precise control of the space between the QDs with the rGO. The latter issue is associated with the prevention of fluorescence quenching. Noticeably, QDs-rGO can absorb the NIR irradiation for PTT and cell death, while the absorbed heat simultaneously increases the temperature and decreases the QDs brightness. This becomes a condition allowing the <span class="italic">in situ</span> measurement of the heat and can indicate the PTT progress. Meanwhile, active targeting and enhanced cell internalisation by conjugated QDs-rGO with targeting or internalisation ligands are demonstrated in <a title="Select to navigate to figure" href="#imgfig2">Fig. 2</a>. The integration of these astonishing features turns this remarkable nanocomposite into a greater candidate for cancer diagnosis, imaging and treatment <span class="italic">via</span> drug molecule delivery and PTT.<a title="Select to navigate to references" href="#cit30"><sup><span class="sup_ref">30</span></sup></a></span>
<br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig2"><a href="/image/article/2020/RA/d0ra00186d/d0ra00186d-f2_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d0ra00186d-f2.tif" src="/image/article/2020/RA/d0ra00186d/d0ra00186d-f2.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 2 </b> <span id="fig2"><span class="graphic_title">QDs-rGO nanocomposites implemented against targeted tumour cells can directly indicate bright fluorescence (blue dots) under the assistance of the QDs (top), while NIR radiation was harvested and absorbed on the rGO surface and thus converted into heat, resulting in cancer/healthy cell death together with a reduction of fluorescence (bottom).<a title="Select to navigate to reference" href="#cit30"><sup><span class="sup_ref">30,70</span></sup></a></span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
<p class="otherpara">Nowadays, chemotherapy treatment is the core clinical therapeutic method for curing up to 100 types of cancer, including lung cancer, prostate cancer, lymphoma cancer and breast cancer. However, low therapeutic positive results happen due to drug allergies and limited cellular uptake, as well as other brutal side effects, such as liver and kidney malfunction, a drop in the fertility rate, nerve and muscle effects and cardiac toxicity. These issues will limit the clinical applications of chemotherapy for patients.<a title="Select to navigate to references" href="#cit71"><sup><span class="sup_ref">71</span></sup></a></p>
<p class="otherpara">PTT mainly works by using laser irradiation, whereby it produces heat elevations and induces the hyperthermia mode towards the tumour tissues. This leads to the denaturation of proteins and disruption of the cell membrane, finally resulting in the irreversible destruction of cancer cells.<a title="Select to navigate to references" href="#cit72"><sup><span class="sup_ref">72</span></sup></a> However, the non-selectivity of tumour tissues and high power density of laser therapy may cause severe side effects to the patient.<a title="Select to navigate to references" href="#cit73"><sup><span class="sup_ref">73</span></sup></a> The abilities of PTA to enhance the selectivity of laser absorption is crucial for the heat factor to be easily provided within the microenvironment of a selected tumour tissue that requires a relatively low power density laser signal.<a title="Select to navigate to reference" href="#cit74"><sup><span class="sup_ref">74–82</span></sup></a> In this context, GO and rGO materials have been broadly nominated as PTAs for both the <span class="italic">in vitro</span> and <span class="italic">in vivo</span> photothermal ablation of cancer cells, which is attributed to their strong light absorbance in the NIR window of the wavelength (<span class="italic">i.e.</span> in the range of 700–1300 nm).<a title="Select to navigate to reference" href="#cit83"><sup><span class="sup_ref">83–93</span></sup></a> Since biological tissues are transparent to such NIR window, a high photothermal conversion efficiency into the tumour tissues will occur due to high-depth light penetration and low tissue-induced light absorption.<a title="Select to navigate to references" href="#cit94"><sup><span class="sup_ref">94</span></sup></a></p>
<p class="otherpara">Therefore, the incorporation of drug delivery and PTT can enhance the effectiveness of the chemotherapeutic route. So far, the local heterogeneous distribution of heat induced by PTT is not a suitable method to encompass cancer cell death, especially for light-omitted areas.<a title="Select to navigate to references" href="#cit71"><sup><span class="sup_ref">71</span></sup></a> As such, the graphene-based nanomaterial is a brilliant light absorbance agent with a high surface area and can be applied with various therapeutic molecules in order to absorb or conjugate with a tumour. To this end, photothermal chemotherapy is done using DOX-loaded rGO-PEG, which exhibits a higher therapeutic efficacy for <span class="italic">in vivo</span> cancer treatments in comparison with chemotherapy or PTT alone.<a title="Select to navigate to references" href="#cit95"><sup><span class="sup_ref">95</span></sup></a> Therefore, the epidermal growth factor receptor (EGFR) antibody reinforced PEGylated nano-sized GO (PEG-NGO) was established to deliver epirubicin (EPI) for tumour targeting and triple therapeutics (<span class="italic">i.e.</span> growth signal blocking, chemotherapy and PTT). This synergistic targeted therapy boosted the local drug concentration by 6.3-fold and yielded ultra-efficient tumour suppression to prolong the survival in mice specimens (&gt;50 days).<a title="Select to navigate to reference" href="#cit30"><sup><span class="sup_ref">30,95</span></sup></a></p>
<p class="otherpara">Recently, a one-pot synthesis route was employed for a relatively new class of photosensitive inorganic nanocomposites that rival liposomes with a combination of hydrophilic and hydrophobic characteristics and have shown superior biocompatibility properties.<a title="Select to navigate to references" href="#cit96"><sup><span class="sup_ref">96</span></sup></a> In general, the useful nanocomposites are made of rGO, mesoporous silicon and amorphous carbon, which are credited with the photon–thermal conversion improvement, active transport drug absorption and cells biocompatibility/penetrability, respectively. The uptake of rGO-based material nanocomposites with a high photothermal conversion efficiency of MDA-MB-231 cells provided a large loading for the hydrophobic drug, (<span class="italic">S</span>)-(+)-camptothecin (CPT) delivery. According to the current body of knowledge, nanocookie–CPT doses accumulatively remain in liver organ for 24 h after an entire treatment. With the well-assembled rGO-MDA-MB-231 cells nanocomposite, the cancer cell were destructed efficiently without any further side effects <span class="italic">in vitro</span> and <span class="italic">in vivo</span>, specifically for both localised drug release and PTT. The results in <a title="Select to navigate to figure" href="#imgfig3">Fig. 3</a> confirm the synergistic effect of PBS + NIR as the benchmark (control), CPT + NIR and nanocookie–CPT + NIR, which were compared to the fundamental CPT and NIR. Lastly, the combination of CPT + NIR with nanocookies with a variation of heating temperatures was also evaluated towards tumour-bearing mice <span class="italic">via</span> MDA-MB231 cell lines.<a title="Select to navigate to references" href="#cit97"><sup><span class="sup_ref">97</span></sup></a></p>
<br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig3"><a href="/image/article/2020/RA/d0ra00186d/d0ra00186d-f3_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d0ra00186d-f3.tif" src="/image/article/2020/RA/d0ra00186d/d0ra00186d-f3.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 3 </b> <span id="fig3"><span class="graphic_title">Infrared thermal images of (a) PBS + NIR (control), CPT + NIR, nanocookie with CPT and NIR, and nanocookie + CPT + NIR with the variation in temperature, (b) the tumour changed into a ‘scab’ (circled) after treatment with the nanocookie + NIR and nanocookie–CPT + NIR specimens after 4 days, (c) body weight change data with different injections, (d) tumour weight changes after a month.<a title="Select to navigate to references" href="#cit97"><sup><span class="sup_ref">97</span></sup></a></span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
<p class="otherpara">Recently, the innovative method of the one-pot hydrothermal synthesis of copper sulfide (CuS) nanoplates incorporated rGO (rGO–CuS composite) was employed as a PTA for the ablation of cancer cells.<a title="Select to navigate to references" href="#cit98"><sup><span class="sup_ref">98</span></sup></a> Here, the CuS nanoplates were loaded onto the rGO surface during the hydrothermal process. Consequently, the synthesised rGO–CuS composites dramatically increased the typical optical absorbance in the NIR region, thus improving the photothermal conversion efficiency compared to GO composite and raw CuS nanoplates. Here, researchers attempted to destroy the cancer cells at a relatively high concentration (200 g mL<small><sup>−1</sup></small>) and under 980 nm laser irradiation. Then, the <span class="italic">in vitro</span> cytotoxicity of CuS and rGO–CuS materials on the cancer cells by using the MTT assay for assessing cell metabolic activity was investigated accordingly. In this comprehensive work, the researchers applied CuS and rGO–CuS at various concentrations, while HeLa cells were incubated without any significant toxicity at a low concentration for 24 h. The results showed that the cytotoxicity was directly proportional to the HeLa cell ratio; whereby, when the CuS/rGO–CuS concentration increased, the cytotoxicity also increased. Moreover, the cellular viabilities were estimated to be greater than 80% when the concentrations of CuS and rGO–CuS were increased to 200 g mL<small><sup>−1</sup></small>. The results thus suggested that the materials did not impose considerable toxicity to the cancer cells. As shown in <a title="Select to navigate to figure" href="#imgfig4">Fig. 4</a>, the rGO–CuS composite exhibited higher cytotoxicity in HeLa cells compared to the raw CuS sample, indicating that the former is an effective PTA for cancer treatment.</p>
<br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig4"><a href="/image/article/2020/RA/d0ra00186d/d0ra00186d-f4_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d0ra00186d-f4.tif" src="/image/article/2020/RA/d0ra00186d/d0ra00186d-f4.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 4 </b> <span id="fig4"><span class="graphic_title">(a) Temperature changes for CuS incorporated with rGO and (b) cell viability of rGO–CuS as compared with raw CuS.<a title="Select to navigate to references" href="#cit98"><sup><span class="sup_ref">98</span></sup></a></span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
<p class="otherpara">In <a title="Select to navigate to figure" href="#imgfig5">Fig. 5</a>, the rGO–CuS composite was observed under confocal microscopy with NIR irradiation of 5 min, specifically under 980 nm NIR at 1 W cm<small><sup>−2</sup></small>. The red-coloured dots represent the dead cells at a power density of 1 W cm<small><sup>−2</sup></small>, which mediated the highest rate of cell death. Here, almost all the cancer cells were destroyed, as indicated by the laser spot (red colour). Unfortunately, limited dead cells were observed by the raw CuS treatment, thereby the results suggest that the rGO–CuS composite was a more efficient PTA for the ablation of cancer cells.<a title="Select to navigate to references" href="#cit98"><sup><span class="sup_ref">98</span></sup></a></p>
<br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig5"><a href="/image/article/2020/RA/d0ra00186d/d0ra00186d-f5_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d0ra00186d-f5.tif" src="/image/article/2020/RA/d0ra00186d/d0ra00186d-f5.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 5 </b> <span id="fig5"><span class="graphic_title">CLSM images of HeLa cells incubated with DMEM medium, CuS and rGO–CuS composite.<a title="Select to navigate to references" href="#cit98"><sup><span class="sup_ref">98</span></sup></a></span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
<p class="otherpara">Similarly, decorated nano-rGO with bovine serum albumin (BSA) was recently developed for use as a PTT system. NS was successfully utilised to suppress breast cancer cells both <span class="italic">in vitro</span> and <span class="italic">in vivo</span>.<a title="Select to navigate to references" href="#cit99"><sup><span class="sup_ref">99</span></sup></a> Similar to other photoacoustic NSs,<a title="Select to navigate to references" href="#cit100"><sup><span class="sup_ref">100</span></sup></a> the <span class="italic">in vitro</span> effect of nano-rGO was tested against MCF-7 cells subjected to an NIR laser at a wavelength of 808 nm and caused apoptosis in the cancer cells in a concentration-dependent manner, as schematically illustrated in <a title="Select to navigate to figure" href="#imgfig6">Fig. 6</a>. Additionally, the mice administered with the nano-rGO showed thermal cell necrosis.</p>
<br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig6"><a href="/image/article/2020/RA/d0ra00186d/d0ra00186d-f6_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d0ra00186d-f6.tif" src="/image/article/2020/RA/d0ra00186d/d0ra00186d-f6.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 6 </b> <span id="fig6"><span class="graphic_title"><span class="italic">In vivo</span> photodynamic therapy of cancer using PEGylated rGO under 808 nm laser irradiation.<a title="Select to navigate to references" href="#cit104"><sup><span class="sup_ref">104</span></sup></a></span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
<p class="otherpara">Obviously, nano-rGOs functionalised with BSA have shown excellent PTT impacts, upon which the NS with an improved passive targeting capacity is introduced for the eradication of different types of solid tumours. The results obtained towards GO-based NS were in agreement with other research works that have shown the detrimental impacts of PEG-rGO on cancer cells.<a title="Select to navigate to references" href="#cit101"><sup><span class="sup_ref">101</span></sup></a> Previously, some <span class="italic">in vivo</span> studies have shown the value of covalent PEG-GO systems and their impact in large part was based on PTT after high-dosage injections (20 mg kg<small><sup>−1</sup></small>) and the implementation of an NIR laser (2 W cm<small><sup>−2</sup></small>).<a title="Select to navigate to references" href="#cit101"><sup><span class="sup_ref">101</span></sup></a></p>
<p class="otherpara">Interestingly, non-covalent PEGylated nano-rGO can absorb noticeably higher NIR than those that are not reduced covalently.<a title="Select to navigate to references" href="#cit102"><sup><span class="sup_ref">102</span></sup></a> Researchers have also revealed that the absorbance volume in the NIR may be a result of recovering p-conjugations in nGO. Besides, the high NIR absorbance of low concentration (20 mg L<small><sup>−1</sup></small>) rGO through the use of a low-power laser (<span class="italic">i.e.</span> 808 nm and 0.6 W cm<small><sup>−2</sup></small>) may be regarded as a strong indicator of the nano-rGO's high photothermal capacity. Moreover, the researchers demonstrated that grafting the tripeptide Arg-Gly-Asp (RGD) peptide ligands to nano-rGOs could lead to active targeting results, thus yielding a better/higher photothermal ablation of the infected cells. In addition, nano-rGO has been proven to be able to load non-covalent DOX molecules through p-stacking. Thus, in addition to its capability for surface modifications, nano-rGO has a great potential for combined targeted PTT and chemotherapy.</p>
<p class="otherpara">Recently, Yang and other researchers demonstrated <span class="italic">in vivo</span> PTT by injecting PEGylated nano-rGO and PEGylated nano-GO into 4T1 tumour-bearing mice intravenously. Following this, they revealed that the tumour size was significantly reduced, while the survival index was highly improved in the PEGylated nano rGO-treated group that also underwent laser irradiation. In the histological examination of various tissues, no clear toxic effects were found in mice treated with PEGylated nano-rGO.<a title="Select to navigate to references" href="#cit103"><sup><span class="sup_ref">103</span></sup></a></p>
<p class="otherpara">In another study, non-covalent PEGylation of the nano-rGO sheet was established, derived <span class="italic">via</span> chemical reduction in order to conjugate a specific quantity of graphene sheets. This offered an increased NIR absorbance by up to 6-fold. Besides, a few of the rGO sheets with amphiphilic surfactants displayed good stability and biocompatibility in biological buffer solutions. The optimised nano-rGO allowed the peptide conjugation of the targeting cancer cells and selective photoablation at a low dose. These are pioneering outcomes involving the reduced GO form taking part in non-covalent PEGylation for biological applications, thereby resulting in a highly effective PTA with a significant absorbance of NIR light towards carbon-based materials.<a title="Select to navigate to references" href="#cit32"><sup><span class="sup_ref">32</span></sup></a> Research has also developed biocompatible rGO sheets potentially for PTT purposes. Here, the nano-rGO sheets were of a smaller size, spanning ∼20 nm, and were developed <span class="italic">via</span> covalent PEGylation through the sonication route. Furthermore, researchers have determined that the chemical reduction of nano-GO can afford up to 6-fold increase in activity and more; consequently, this improves the NIR absorbance for the PTA, which is also comparable to CNTs and gold-based nanomaterials. Then, they demonstrated the functionalisation of nano-rGO <span class="italic">via</span> specific targeting ligands for a selective type of cancer cell with photothermal ablation <span class="italic">in vitro</span>. Attempts were made to try systematic <span class="italic">in vivo</span> tests with a small dose of nano-rGO for PTT on tumours present in mice bodies and at very low laser power. The result showed that the high NIR absorbance of nano-rGO allowed for the efficient photothermal heating of solutions at low concentrations of nano-rGO (<a title="Select to navigate to figure" href="#imgfig7">Fig. 7</a>). Additionally, a small concentration of the nano-rGO (∼20 mg L<small><sup>−1</sup></small>) exhibited rapid photothermal heating, which occurred upon its irradiation by a low-power laser at 0.6 W cm<small><sup>−2</sup></small> (<a title="Select to navigate to figure" href="#imgfig8">Fig. 8</a>).</p>
<br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig7"><a href="/image/article/2020/RA/d0ra00186d/d0ra00186d-f7_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d0ra00186d-f7.tif" src="/image/article/2020/RA/d0ra00186d/d0ra00186d-f7.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 7 </b> <span id="fig7"><span class="graphic_title">(a) Samples of the PEGylated-based solutions with covalently formed nano-GO and nano-rGO, (b) UV-vis spectra. Photothermal heating curves of (c) nano-rGO and (d) nano-GO solutions.<a title="Select to navigate to references" href="#cit32"><sup><span class="sup_ref">32</span></sup></a></span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
<br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig8"><a href="/image/article/2020/RA/d0ra00186d/d0ra00186d-f8_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d0ra00186d-f8.tif" src="/image/article/2020/RA/d0ra00186d/d0ra00186d-f8.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 8 </b> <span id="fig8"><span class="graphic_title">(a) Thermal images of pellets with nontreated U87MG cells (control specimen shown at left), cells with added nano-rGO-RGD (middle) and cells treated by nano-rGO-RAD (right), respectively, irradiated under an 808 nm laser at a power of 15.3 W cm<small><sup>−2</sup></small> for 8 min duration. (b) Cell pellet heating temperature against irradiation time curves and (c) cell viability after 24 h irradiation.<a title="Select to navigate to references" href="#cit32"><sup><span class="sup_ref">32</span></sup></a></span></span></td><td class="pushTitleLeft"> </td></tr></table></div>

<h2 id="sect851"><span class="a_heading">4. Future perspectives of PTT</span></h2>
<span>A short time after finding the bulk quantity of graphene, its derivatives, such as GO, CNTs and other graphene-based nanomaterials, were considered as low-cost building blocks for advanced methodologies and for the development of medical applications, which are unlimited in imagination. For example, the variety possible with of GO reduction and its incorporation with different materials for building composites and new novel functional materials are indeed endless. Note that polymers and composites have already been added to GO additives, either in their nanoparticle forms for mechanical stabilisation or to facilitate the processing itself. Similarly, graphene is highly compatible biologically and able to function as an active support for mouse fibroblast cells, thus suggesting its use in encapsulating enzymes, serving as a template for DNA-based therapy, or culturing cells.</span>
<p class="otherpara">Furthermore, the uniqueness of both the physical and chemical properties (<span class="italic">i.e.</span> strong NIR absorption with conjugated π–π surface stacking) of nanographene oxide has led to a dedicated and major amount of works utilising rGO in PTT, yielding a synergistic effect in cancer cell destruction. The assumption is that a similar strategy may also be applied in advanced graphene-based chemotherapies, drug delivery and gene transfection. As graphene, GO and rGO are great drug carriers for anticancer treatments, it is anticipated that in the near future, it will be convenient to combine chemotherapy with PTT for targeted drug delivery and treatment, without the need to use additional drug carriers. Regardless, the low toxicity of nano-GO and rGO has been proven in various research works, rendering the inherent nonbiodegradability of graphene-based materials as the last major concern in clinical applications.</p>

<h2 id="sect857"><span class="a_heading">5. Conclusion</span></h2>
<span>rGO has attracted great attention for its outstanding properties, and because it can be easily synthesised <span class="italic">via</span> chemical or mechanical approaches. In contrast, PTT is capable of undertaking thermal ablation against targeted cancer cells. Moreover, numerous established ideas have been suggested regarding graphene-based nanomaterials and their derivatives as aggressively promising and active PTT agents, especially in combination therapies for cancer treatment. Several key ideas were thus reviewed in designing a graphene-based nanostructure with multifunctional PTT or combination therapy abilities in order to achieve efficient treatment for future and advanced clinical purposes. For instance, the combination of physical properties related to a stimuli-responsive targeted drug carrier with a high concentration of PTT is needed in order to develop other treatments. Indeed, graphene could act as a PTA agent and exhibited strong NIR absorbance towards defeating cancer cells. Due to its novelty as a light-absorbing nanoparticle, it could serve for specific therapeutic reagent delivery to a targeted tumour area <span class="italic">via</span> PTT. Additionally, thermal enhancement of the therapeutic agents incorporated with graphene, instead of applying conventional chemotherapy treatments, could minimise several side effects that a patient may encounter.</span>

<h2 id="sect863"><span class="a_heading">Conflicts of interest</span></h2>
<span>There are no conflicts to declare.</span>


<h2 id="sect867"><span class="a_heading">Acknowledgements</span></h2><span>This work was financially supported by Impact-Oriented Interdisciplinary Research Grant (No. IIRG018A-2019), Global Collaborative Programme-SATU Joint Research Scheme (No. ST012-2019), BOLD2025 Grant (No. 10436494/B/2019008), and Internal Research Grant Opex (No. RJO10517919/iRMC/Publication) under Universiti Tenaga Nasional Sdn. Bhd., Malaysia.</span>
<span id="sect869"><h2 id="sect866"><span class="a_heading">References</span></h2></span><ol type="1"><li><span id="cit1">Y. Liu, <span class="italic">et al.</span>, Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer, <span class="italic">Chem. Soc. Rev.</span>, 2019, <span class="bold">48</span>(7), 2053–2108 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C8CS00618K&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C8CS00618K">RSC</a>.</span></li><li><span id="cit2">S. M. Mousavi, <span class="italic">et al.</span>, Graphene Nano-ribbon Based high potential and Efficiency for DNA, Cancer therapy and drug delivery applications, <span class="italic">Drug Metab. Rev.</span>, 2019, 1–35 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Drug%20Metab.%20Rev.%5BJour%5D%20AND%20%5Bvolume%5D%20AND%201%5Bpage%5D%20and%202019%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li><li><span id="cit3">A. Savardashtaki, <span class="italic">et al.</span>, Core-Shell Nanofibers: A New Horizon in Controlling the Drug Release, <span class="italic">Curr. Cancer Ther. Rev.</span>, 2017, <span class="bold">13</span>, 1–26 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Curr.%20Cancer%20Ther.%20Rev.%5BJour%5D%20AND%2013%5Bvolume%5D%20AND%201%5Bpage%5D%20and%202017%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li><li><span id="cit4">R. Ravanshad, <span class="italic">et al.</span>, Application of nanoparticles in cancer detection by Raman scattering based techniques, <span class="italic">Nano Rev. Exp.</span>, 2018, <span class="bold">9</span>, 1373551 <a target="_blank" class="DOILink" href="https://doi.org/10.1080/20022727.2017.1373551" title="DOI Link to resource 10.1080/20022727.2017.1373551">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=30410710%5Buid%5D" title="PubMed Link to resource 30410710">PubMed</a>.</span></li><li><span id="cit5">N. Goodarzian, <span class="italic">et al.</span>, Modification of Physical, Mechanical and Electrical Properties of Reinforced Epoxy Phenol Novolac with Nano Cobalt Acrylate and Carbon Nanotubes, <span class="italic">Prog. Rubber, Plast. Recycl. Technol.</span>, 2018, <span class="bold">34</span>(2), 105–114 <a target="_blank" class="DOILink" href="https://doi.org/10.1177/147776061803400203" title="DOI Link to resource 10.1177/147776061803400203">CrossRef</a>.</span></li><li><span id="cit6">S. M. Mousavi, <span class="italic">et al.</span>, Modification of Polypropylene-Starch Blend by Eggshell Nano-Particle, EVA and Maleic Anhydride to Improve Biodegradability and Thermal Properties, <span class="italic">Int. J. Chem. Sci.</span>, 2018, <span class="bold">15</span>, 225 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Int.%20J.%20Chem.%20Sci.%5BJour%5D%20AND%2015%5Bvolume%5D%20AND%20225%5Bpage%5D%20and%202018%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li><li><span id="cit7">Z. Farazi, <span class="italic">et al.</span>, Preparation of LDPE/EVA/PE-MA, Nano Clay Blend Composite in the Stage Potassium Sorbate (KS) and Garlic Oil (GO) as an Antimicrobial Substance, <span class="italic">Polym. Sci. U.S.S.R.</span>, 2018, <span class="bold">4</span>, 1–12 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Polym.%20Sci.%20U.S.S.R.%5BJour%5D%20AND%204%5Bvolume%5D%20AND%201%5Bpage%5D%20and%202018%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li><li><span id="cit8">A. Zakeri, <span class="italic">et al.</span>, Polyethylenimine-based nanocarriers in co-delivery of drug and gene: a developing horizon, <span class="italic">Nano Rev. Exp.</span>, 2018, <span class="bold">9</span>, 1488497 <a target="_blank" class="DOILink" href="https://doi.org/10.1080/20022727.2018.1488497" title="DOI Link to resource 10.1080/20022727.2018.1488497">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=30410712%5Buid%5D" title="PubMed Link to resource 30410712">PubMed</a>.</span></li><li><span id="cit9">S. M. Mousavi, <span class="italic">et al.</span>, Development of Clay Nanoparticles Toward Bio and Medical Applications, <span class="italic">Current Topics in the Utilization of Clay in Industrial and Medical Applications</span>,  2018, pp. 167–191 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Current%20Topics%20in%20the%20Utilization%20of%20Clay%20in%20Industrial%20and%20Medical%20Applications%5BJour%5D%20AND%20%5Bvolume%5D%20AND%20%5Bpage%5D%20and%202018%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li><li><span id="cit10">S. M. Mousavi, <span class="italic">et al.</span>, Nanosensors for Chemical and Biological and Medical Applications, <span class="italic">Med. Chem.</span>, 2018, <span class="bold">8</span>(8), 205–217 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Med.%20Chem.%5BJour%5D%20AND%208%5Bvolume%5D%20AND%20205%5Bpage%5D%20and%202018%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li><li><span id="cit11">J. Pardo, Z. Peng and R. Leblanc, Cancer targeting and drug delivery using carbon-based quantum dots and nanotubes, <span class="italic">Molecules</span>, 2018, <span class="bold">23</span>(2), 378 <a target="_blank" class="DOILink" href="https://doi.org/10.3390/molecules23020378" title="DOI Link to resource 10.3390/molecules23020378">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29439409%5Buid%5D" title="PubMed Link to resource 29439409">PubMed</a>.</span></li><li><span id="cit12">Z. Chen, <span class="italic">et al.</span>, The advances of carbon nanotubes in cancer diagnostics and therapeutics, <span class="italic">J. Nanomater.</span>, 2017, <span class="bold">2017</span>, 1–13 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=J.%20Nanomater.%5BJour%5D%20AND%202017%5Bvolume%5D%20AND%201%5Bpage%5D%20and%202017%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li><li><span id="cit13">R. D. Bolskar, Fullerenes for Drug Delivery, in <span class="italic">Encyclopedia of Nanotechnology</span>, ed. B. Bhushan, Springer Netherlands, Dordrecht,  2016, pp. 1267–1281 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Encyclopedia%20of%20Nanotechnology%5BJour%5D%20AND%20%5Bvolume%5D%20AND%20%5Bpage%5D%20and%202016%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li><li><span id="cit14">S. C. Patel, <span class="italic">et al.</span>, Graphene-based platforms for cancer therapeutics, <span class="italic">Ther. Delivery</span>, 2016, <span class="bold">7</span>(2), 101–116 <a target="_blank" class="DOILink" href="https://doi.org/10.4155/tde.15.93" title="DOI Link to resource 10.4155/tde.15.93">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28XhtlWrsLk%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=26769305%5Buid%5D" title="PubMed Link to resource 26769305">PubMed</a>.</span></li><li><span id="cit15">N. Krasteva, <span class="italic">et al.</span>, Aminated Graphene Oxide as a Potential New Therapy for Colorectal Cancer. Oxidative medicine and cellular longevity, <span class="italic">Oxid. Med. Cell. Longevity</span>, 2019, <span class="bold">2019</span>, 1–15 <a target="_blank" class="DOILink" href="https://doi.org/10.1155/2019/3738980" title="DOI Link to resource 10.1155/2019/3738980">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=31015889%5Buid%5D" title="PubMed Link to resource 31015889">PubMed</a>.</span></li><li><span id="cit16">E. Campbell, <span class="italic">et al.</span>, Graphene Oxide as a Multifunctional Platform for Intracellular Delivery, Imaging, and Cancer Sensing, <span class="italic">Sci. Rep.</span>, 2019, <span class="bold">9</span>(1), 416 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/s41598-018-36617-4" title="DOI Link to resource 10.1038/s41598-018-36617-4">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ASTN%3A280%3ADC%252BB3cjksFyjug%253D%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=30674914%5Buid%5D" title="PubMed Link to resource 30674914">PubMed</a>.</span></li><li><span id="cit17">J. Dong, Anticancer effect and feasibility study of hyperthermia treatment of pancreatic cancer using magnetic nanoparticles, <span class="italic">Oncol. Rep.</span>, 2011, 719–726 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Oncol.%20Rep.%5BJour%5D%20AND%20%5Bvolume%5D%20AND%20719%5Bpage%5D%20and%202011%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li><li><span id="cit18">R. Tietze, <span class="italic">et al.</span>, Nanoparticles for cancer therapy using magnetic forces, <span class="italic">Nanomedicine</span>, 2012, <span class="bold">7</span>(3), 447–457 <a target="_blank" class="DOILink" href="https://doi.org/10.2217/nnm.12.10" title="DOI Link to resource 10.2217/nnm.12.10">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38XjtlKltrk%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=22385201%5Buid%5D" title="PubMed Link to resource 22385201">PubMed</a>.</span></li><li><span id="cit19">M. Thangamuthu, <span class="italic">et al.</span>, Graphene-and Graphene Oxide-Based Nanocomposite Platforms for Electrochemical Biosensing Applications, <span class="italic">Int. J. Mol. Sci.</span>, 2019, <span class="bold">20</span>(12), 2975 <a target="_blank" class="DOILink" href="https://doi.org/10.3390/ijms20122975" title="DOI Link to resource 10.3390/ijms20122975">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXhtFGqtro%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=31216691%5Buid%5D" title="PubMed Link to resource 31216691">PubMed</a>.</span></li><li><span id="cit20">P. Suvarnaphaet and S. Pechprasarn, Graphene-based materials for biosensors: A review, <span class="italic">Sensors</span>, 2017, <span class="bold">17</span>(10), 2161 <a target="_blank" class="DOILink" href="https://doi.org/10.3390/s17102161" title="DOI Link to resource 10.3390/s17102161">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=28934118%5Buid%5D" title="PubMed Link to resource 28934118">PubMed</a>.</span></li><li><span id="cit21">S. F. Kiew, <span class="italic">et al.</span>, Assessing biocompatibility of graphene oxide-based nanocarriers: a review, <span class="italic">J. Controlled Release</span>, 2016, <span class="bold">226</span>, 217–228 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.jconrel.2016.02.015" title="DOI Link to resource 10.1016/j.jconrel.2016.02.015">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28XivVCrsbg%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=26873333%5Buid%5D" title="PubMed Link to resource 26873333">PubMed</a>.</span></li><li><span id="cit22">H. Su, <span class="italic">et al.</span>, Aggregation prevention: reduction of graphene oxide in mixed medium of alkylphenol polyoxyethylene (7) ether and 2-methoxyethanol, <span class="italic">RSC Adv.</span>, 2018, <span class="bold">8</span>(68), 39140–39148 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C8RA07263A&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C8RA07263A">RSC</a>.</span></li><li><span id="cit23">W. Sun, <span class="italic">et al.</span>, Preparation, Characterization and Application of Multi-Mode Imaging Functional Graphene Au-Fe3O4 Magnetic Nanocomposites, <span class="italic">Materials</span>, 2019, <span class="bold">12</span>(12), 1978 <a target="_blank" class="DOILink" href="https://doi.org/10.3390/ma12121978" title="DOI Link to resource 10.3390/ma12121978">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXit12lsrs%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=31248197%5Buid%5D" title="PubMed Link to resource 31248197">PubMed</a>.</span></li><li><span id="cit24">A. N. Nikam, <span class="italic">et al.</span>, Design and development of thiolated graphene oxide nanosheets for brain tumor targeting, <span class="italic">Int. J. Polym. Mater. Polym. Biomater.</span>, 2019, 1–11 <a target="_blank" class="DOILink" href="https://doi.org/10.1080/00914037.2019.1596911" title="DOI Link to resource 10.1080/00914037.2019.1596911">CrossRef</a>.</span></li><li><span id="cit25">S. Shi, <span class="italic">et al.</span>, VEGFR targeting leads to significantly enhanced tumor uptake of nanographene oxide in vivo, <span class="italic">Biomaterials</span>, 2015, <span class="bold">39</span>, 39–46 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2014.10.061" title="DOI Link to resource 10.1016/j.biomaterials.2014.10.061">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXhvVKltL3F" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=25477170%5Buid%5D" title="PubMed Link to resource 25477170">PubMed</a>.</span></li><li><span id="cit26">C. England, <span class="italic">et al.</span>, Radiolabeled long circulating nanoparticles for re-assessing the enhanced permeability and retention effect in peripheral arterial disease, <span class="italic">J. Nucl. Med.</span>, 2016, <span class="bold">57</span>(suppl. 2), 65 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=J.%20Nucl.%20Med.%5BJour%5D%20AND%2057%5Bvolume%5D%20AND%2065%5Bpage%5D%20and%202016%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li><li><span id="cit27">P. Navya, <span class="italic">et al.</span>, Current trends and challenges in cancer management and therapy using designer nanomaterials, <span class="italic">Nano Convergence</span>, 2019, <span class="bold">6</span>(1), 23 <a target="_blank" class="DOILink" href="https://doi.org/10.1186/s40580-019-0193-2" title="DOI Link to resource 10.1186/s40580-019-0193-2">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ASTN%3A280%3ADC%252BB3Mznt1GlsQ%253D%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=31304563%5Buid%5D" title="PubMed Link to resource 31304563">PubMed</a>.</span></li><li><span id="cit28">M. K. Rabchinskii, <span class="italic">et al.</span>, Facile reduction of graphene oxide suspensions and films using glass wafers, <span class="italic">Sci. Rep.</span>, 2018, <span class="bold">8</span>(1), 14154 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/s41598-018-32488-x" title="DOI Link to resource 10.1038/s41598-018-32488-x">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=30237450%5Buid%5D" title="PubMed Link to resource 30237450">PubMed</a>.</span></li><li><span id="cit29">G. Gonçalves, <span class="italic">et al.</span>, Breakdown into nanoscale of graphene oxide: confined hot spot atomic reduction and fragmentation, <span class="italic">Sci. Rep.</span>, 2014, <span class="bold">4</span>, 6735 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/srep06735" title="DOI Link to resource 10.1038/srep06735">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=25339424%5Buid%5D" title="PubMed Link to resource 25339424">PubMed</a>.</span></li><li><span id="cit30">Y.-W. Chen, <span class="italic">et al.</span>, Functionalized graphene nanocomposites for enhancing photothermal therapy in tumor treatment, <span class="italic">Adv. Drug Delivery Rev.</span>, 2016, <span class="bold">105</span>, 190–204 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.addr.2016.05.022" title="DOI Link to resource 10.1016/j.addr.2016.05.022">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28XptlCnsLg%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=27262922%5Buid%5D" title="PubMed Link to resource 27262922">PubMed</a>.</span></li><li><span id="cit31">M. Quinn, T. Wang and S. Notley, Surfactant-exfoliated graphene as a near-infrared photothermal ablation agent, <span class="italic">Biomedical Physics &amp; Engineering Express</span>, 2018, <span class="bold">4</span>(2), 025020 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Biomedical%20Physics%20&amp;%20Engineering%20Express%5BJour%5D%20AND%204%5Bvolume%5D%20AND%20025020%5Bpage%5D%20and%202018%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li><li><span id="cit32">J. T. Robinson, <span class="italic">et al.</span>, Ultrasmall reduced graphene oxide with high near-infrared absorbance for photothermal therapy, <span class="italic">J. Am. Chem. Soc.</span>, 2011, <span class="bold">133</span>(17), 6825–6831 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ja2010175" title="DOI Link to resource 10.1021/ja2010175">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXksVeitb4%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21476500%5Buid%5D" title="PubMed Link to resource 21476500">PubMed</a>.</span></li><li><span id="cit33">J. Han, <span class="italic">et al.</span>, Photothermal therapy of cancer cells using novel hollow gold nanoflowers, <span class="italic">Int. J. Nanomed.</span>, 2014, <span class="bold">9</span>, 517 <a target="_blank" class="DOILink" href="https://doi.org/10.2217/nnm.13.224" title="DOI Link to resource 10.2217/nnm.13.224">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=24787440%5Buid%5D" title="PubMed Link to resource 24787440">PubMed</a>.</span></li><li><span id="cit34">Y. Cai, <span class="italic">et al.</span>, Optical nano-agents in the second near-infrared window for biomedical applications, <span class="italic">Chem. Soc. Rev.</span>, 2019, <span class="bold">48</span>(1), 22–37 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C8CS00494C&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C8CS00494C">RSC</a>.</span></li><li><span id="cit35">H. Kim and D. Lee, Near-infrared-responsive cancer photothermal and photodynamic therapy using gold nanoparticles, <span class="italic">Polymers</span>, 2018, <span class="bold">10</span>(9), 961 <a target="_blank" class="DOILink" href="https://doi.org/10.3390/polym10090961" title="DOI Link to resource 10.3390/polym10090961">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=30960886%5Buid%5D" title="PubMed Link to resource 30960886">PubMed</a>.</span></li><li><span id="cit36">C. Christie, <span class="italic">et al.</span>, Photothermal therapy employing gold nanoparticle-loaded macrophages as delivery vehicles: comparing the efficiency of nanoshells versus nanorods, <span class="italic">J. Environ. Pathol., Toxicol. Oncol.</span>, 2017, <span class="bold">36</span>(3), 229–235 <a target="_blank" class="DOILink" href="https://doi.org/10.1615/JEnvironPatholToxicolOncol.2017021545" title="DOI Link to resource 10.1615/JEnvironPatholToxicolOncol.2017021545">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29283336%5Buid%5D" title="PubMed Link to resource 29283336">PubMed</a>.</span></li><li><span id="cit37">A. C. Doughty, <span class="italic">et al.</span>, Nanomaterial applications in photothermal therapy for cancer, <span class="italic">Materials</span>, 2019, <span class="bold">12</span>(5), 779 <a target="_blank" class="DOILink" href="https://doi.org/10.3390/ma12050779" title="DOI Link to resource 10.3390/ma12050779">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1MXitlCltrrI" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=30866416%5Buid%5D" title="PubMed Link to resource 30866416">PubMed</a>.</span></li><li><span id="cit38">Z. Sobhani, <span class="italic">et al.</span>, Photothermal therapy of melanoma tumor using multiwalled carbon nanotubes, <span class="italic">Int. J. Nanomed.</span>, 2017, <span class="bold">12</span>, 4509 <a target="_blank" class="DOILink" href="https://doi.org/10.2147/IJN.S134661" title="DOI Link to resource 10.2147/IJN.S134661">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXitVGhtLjL" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=28684911%5Buid%5D" title="PubMed Link to resource 28684911">PubMed</a>.</span></li><li><span id="cit39">Y. Zhu, <span class="italic">et al.</span>, Decorating gold nanostars with multiwalled carbon nanotubes for photothermal therapy, <span class="italic">R. Soc. Open Sci.</span>, 2018, <span class="bold">5</span>(8), 180159 <a target="_blank" class="DOILink" href="https://doi.org/10.1098/rsos.180159" title="DOI Link to resource 10.1098/rsos.180159">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=30225009%5Buid%5D" title="PubMed Link to resource 30225009">PubMed</a>.</span></li><li><span id="cit40">L. Shao, <span class="italic">et al.</span>, Mesoporous silica coated polydopamine functionalized reduced graphene oxide for synergistic targeted chemo-photothermal therapy, <span class="italic">ACS Appl. Mater. Interfaces</span>, 2017, <span class="bold">9</span>(2), 1226–1236 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsami.6b11209" title="DOI Link to resource 10.1021/acsami.6b11209">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28XitFamsrfP" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=28004583%5Buid%5D" title="PubMed Link to resource 28004583">PubMed</a>.</span></li><li><span id="cit41">X. Chen, <span class="italic">et al.</span>, Infrared heating of reduced graphene oxide nanosheets as photothermal radiation therapeutic agents for tumor regressions, <span class="italic">Mater. Res. Express</span>, 2019, <span class="bold">6</span>(8), 085080 <a target="_blank" class="DOILink" href="https://doi.org/10.1088/2053-1591/ab13c3" title="DOI Link to resource 10.1088/2053-1591/ab13c3">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1MXhvV2qtbzN" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit42">H. Liu, <span class="italic">et al.</span>, Glucose-reduced graphene oxide with excellent biocompatibility and photothermal efficiency as well as drug loading, <span class="italic">Nanoscale Res. Lett.</span>, 2016, <span class="bold">11</span>(1), 211 <a target="_blank" class="DOILink" href="https://doi.org/10.1186/s11671-016-1423-8" title="DOI Link to resource 10.1186/s11671-016-1423-8">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=27094825%5Buid%5D" title="PubMed Link to resource 27094825">PubMed</a>.</span></li><li><span id="cit43">Y. Pang, <span class="italic">et al.</span>, Artesunate-modified nano-graphene oxide for chemo-photothermal cancer therapy, <span class="italic">Oncotarget</span>, 2017, <span class="bold">8</span>(55), 93800 <a target="_blank" class="DOILink" href="https://doi.org/10.18632/oncotarget.21191" title="DOI Link to resource 10.18632/oncotarget.21191">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29212190%5Buid%5D" title="PubMed Link to resource 29212190">PubMed</a>.</span></li><li><span id="cit44">J. Wu, <span class="italic">et al.</span>, Photothermal Effects of Reduced Graphene Oxide on Pancreatic Cancer, <span class="italic">Technol. Cancer Res. Treat.</span>, 2018, <span class="bold">17</span>, 1533034618768637 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Technol.%20Cancer%20Res.%20Treat.%5BJour%5D%20AND%2017%5Bvolume%5D%20AND%201533034618768637%5Bpage%5D%20and%202018%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li><li><span id="cit45">R. Lima-Sousa, <span class="italic">et al.</span>, Hyaluronic acid functionalized green reduced graphene oxide for targeted cancer photothermal therapy, <span class="italic">Carbohydr. Polym.</span>, 2018, <span class="bold">200</span>, 93–99 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.carbpol.2018.07.066" title="DOI Link to resource 10.1016/j.carbpol.2018.07.066">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXhsVWqs73E" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=30177213%5Buid%5D" title="PubMed Link to resource 30177213">PubMed</a>.</span></li><li><span id="cit46">K. Turcheniuk, <span class="italic">et al.</span>, Plasmonic photothermal cancer therapy with gold nanorods/reduced graphene oxide core/shell nanocomposites, <span class="italic">RSC Adv.</span>, 2016, <span class="bold">6</span>(2), 1600–1610 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C5RA24662H&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C5RA24662H">RSC</a>.</span></li><li><span id="cit47">M. S. C. dos Santos, <span class="italic">et al.</span>, Nanographene oxide-methylene blue as phototherapies platform for breast tumor ablation and metastasis prevention in a syngeneic orthotopic murine model, <span class="italic">J. Nanobiotechnol.</span>, 2018, <span class="bold">16</span>(1), 9 <a target="_blank" class="DOILink" href="https://doi.org/10.1186/s12951-018-0333-6" title="DOI Link to resource 10.1186/s12951-018-0333-6">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29382332%5Buid%5D" title="PubMed Link to resource 29382332">PubMed</a>.</span></li><li><span id="cit48">J. Yu, <span class="italic">et al.</span>, Improved anticancer photothermal therapy using the bystander effect enhanced by antiarrhythmic peptide conjugated dopamine-modified reduced graphene oxide nanocomposite, <span class="italic">Adv. Healthcare Mater.</span>, 2017, <span class="bold">6</span>(2), 1600804 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adhm.201600804" title="DOI Link to resource 10.1002/adhm.201600804">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=27860462%5Buid%5D" title="PubMed Link to resource 27860462">PubMed</a>.</span></li><li><span id="cit49">A. T. Smith, <span class="italic">et al.</span>, Synthesis, properties, and applications of graphene oxide/reduced graphene oxide and their nanocomposites, <span class="italic">Nano Materials Science</span>, 2019, <span class="bold">1</span>(1), 31–47 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.nanoms.2019.02.004" title="DOI Link to resource 10.1016/j.nanoms.2019.02.004">CrossRef</a>.</span></li><li><span id="cit50">A. Ahmad, <span class="italic">et al.</span>, Preparation of a chemically reduced graphene oxide reinforced epoxy resin polymer as a composite for electromagnetic interference shielding and microwave-absorbing applications, <span class="italic">Polymers</span>, 2018, <span class="bold">10</span>(11), 1180 <a target="_blank" class="DOILink" href="https://doi.org/10.3390/polym10111180" title="DOI Link to resource 10.3390/polym10111180">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=30961105%5Buid%5D" title="PubMed Link to resource 30961105">PubMed</a>.</span></li><li><span id="cit51">M. Zainuddin, <span class="italic">et al.</span>, Synthesis of reduced Graphene Oxide (rGO) using different treatments of Graphene Oxide (GO), in <span class="italic">IOP Conference Series: Materials Science and Engineering</span>, IOP Publishing,  2018 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=IOP%20Conference%20Series:%20Materials%20Science%20and%20Engineering%5BJour%5D%20AND%20%5Bvolume%5D%20AND%20%5Bpage%5D%20and%202018%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li><li><span id="cit52">F. W. Low, C. W. Lai and S. B. A. Hamid, One-step hydrothermal synthesis of titanium dioxide decorated on reduced graphene oxide for dye-sensitised solar cells application, <span class="italic">Int. J. Nanotechnol.</span>, 2018, <span class="bold">15</span>(1–3), 78–92 <a target="_blank" class="DOILink" href="https://doi.org/10.1504/IJNT.2018.089561" title="DOI Link to resource 10.1504/IJNT.2018.089561">CrossRef</a>.</span></li><li><span id="cit53">F. W. Low, <span class="italic">et al.</span>, An investigation on titanium doping in reduced graphene oxide by RF magnetron sputtering for dye-sensitized solar cells, <span class="italic">Sol. Energy</span>, 2019, <span class="bold">188</span>, 10–18 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.solener.2019.05.069" title="DOI Link to resource 10.1016/j.solener.2019.05.069">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXls12ltrk%253D" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit54">F. W. Low, C. W. Lai and S. B. A. Hamid, Study of reduced graphene oxide film incorporated of TiO<small><sub>2</sub></small> species for efficient visible light driven dye-sensitized solar cell, <span class="italic">J. Mater. Sci.: Mater. Electron.</span>, 2017, <span class="bold">28</span>(4), 3819–3836 <a target="_blank" class="DOILink" href="https://doi.org/10.1007/s10854-016-5993-0" title="DOI Link to resource 10.1007/s10854-016-5993-0">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28XhvVSnur%252FJ" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit55">F. W. Low, C. W. Lai and S. B. A. Hamid, Surface modification of reduced graphene oxide film by Ti ion implantation technique for high dye-sensitized solar cells performance, <span class="italic">Ceram. Int.</span>, 2017, <span class="bold">43</span>(1), 625–633 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.ceramint.2016.09.205" title="DOI Link to resource 10.1016/j.ceramint.2016.09.205">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28Xhs1als7jI" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit56">G. Vinodhkumar, <span class="italic">et al.</span>, Reduced graphene oxide based on simultaneous detection of neurotransmitters, <span class="italic">Progress in Chemical and Biochemical Research</span>, 2018, <span class="bold">1</span>, 40–49 <a target="_blank" class="DOILink" href="https://doi.org/10.29088/SAMI/PCBR.2018.1.4049" title="DOI Link to resource 10.29088/SAMI/PCBR.2018.1.4049">CrossRef</a>.</span></li><li><span id="cit57">X. Y. Gu, <span class="italic">et al.</span>, Effect of TiO<small><sub>2</sub></small>-rGO heterojunction on electron collection efficiency and mechanical properties of fiber-shaped dye-sensitized solar cells, <span class="italic">J. Phys. D: Appl. Phys.</span>, 2018, <span class="bold">52</span>(9), 1–27 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=J.%20Phys.%20D:%20Appl.%20Phys.%5BJour%5D%20AND%2052%5Bvolume%5D%20AND%201%5Bpage%5D%20and%202018%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li><li><span id="cit58">A. Domínguez-Bajo, <span class="italic">et al.</span>, Myelinated axons and functional blood vessels populate mechanically compliant rGO foams in chronic cervical hemisected rats, <span class="italic">Biomaterials</span>, 2019, <span class="bold">192</span>, 461–474 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2018.11.024" title="DOI Link to resource 10.1016/j.biomaterials.2018.11.024">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=30502723%5Buid%5D" title="PubMed Link to resource 30502723">PubMed</a>.</span></li><li><span id="cit59">S. Stankovich, <span class="italic">et al.</span>, Stable aqueous dispersions of graphitic nanoplatelets via the reduction of exfoliated graphite oxide in the presence of poly (sodium 4-styrenesulfonate), <span class="italic">J. Mater. Chem.</span>, 2006, <span class="bold">16</span>(2), 155–158 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=B512799H&amp;newsite=1" title="Link to RSC resource DOI:10.1039/B512799H">RSC</a>.</span></li><li><span id="cit60">D. Li and R. B. Kaner, Graphene-based materials, <span class="italic">Science</span>, 2008, <span class="bold">320</span>(5880), 1170–1171 <a target="_blank" class="DOILink" href="https://doi.org/10.1126/science.1158180" title="DOI Link to resource 10.1126/science.1158180">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1cXntFeqtLk%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=18511678%5Buid%5D" title="PubMed Link to resource 18511678">PubMed</a>.</span></li><li><span id="cit61">H. Chen, <span class="italic">et al.</span>, Mechanically strong, electrically conductive, and biocompatible graphene paper, <span class="italic">Adv. Mater.</span>, 2008, <span class="bold">20</span>(18), 3557–3561 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adma.200800757" title="DOI Link to resource 10.1002/adma.200800757">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1cXht1SgtbjF" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit62">S. Stankovich, <span class="italic">et al.</span>, Synthesis of graphene-based nanosheets via chemical reduction of exfoliated graphite oxide, <span class="italic">Carbon</span>, 2007, <span class="bold">45</span>(7), 1558–1565 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.carbon.2007.02.034" title="DOI Link to resource 10.1016/j.carbon.2007.02.034">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2sXmtVGkur4%253D" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit63">X. Li, <span class="italic">et al.</span>, Highly conducting graphene sheets and Langmuir–Blodgett films, <span class="italic">Nat. Nanotechnol.</span>, 2008, <span class="bold">3</span>(9), 538 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/nnano.2008.210" title="DOI Link to resource 10.1038/nnano.2008.210">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1cXhtVOqsLrO" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit64">H. A. Becerril, <span class="italic">et al.</span>, Evaluation of solution-processed reduced graphene oxide films as transparent conductors, <span class="italic">ACS Nano</span>, 2008, <span class="bold">2</span>(3), 463–470 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/nn700375n" title="DOI Link to resource 10.1021/nn700375n">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1cXhslChtrw%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=19206571%5Buid%5D" title="PubMed Link to resource 19206571">PubMed</a>.</span></li><li><span id="cit65">X. Li, <span class="italic">et al.</span>, Simultaneous nitrogen doping and reduction of graphene oxide, <span class="italic">J. Am. Chem. Soc.</span>, 2009, <span class="bold">131</span>(43), 15939–15944 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ja907098f" title="DOI Link to resource 10.1021/ja907098f">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1MXht1Gju7%252FM" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=19817436%5Buid%5D" title="PubMed Link to resource 19817436">PubMed</a>.</span></li><li><span id="cit66">G. Williams, B. Seger and P. V. Kamat, TiO<small><sub>2</sub></small>-graphene nanocomposites. UV-assisted photocatalytic reduction of graphene oxide, <span class="italic">ACS Nano</span>, 2008, <span class="bold">2</span>(7), 1487–1491 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/nn800251f" title="DOI Link to resource 10.1021/nn800251f">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1cXotFCmsL0%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=19206319%5Buid%5D" title="PubMed Link to resource 19206319">PubMed</a>.</span></li><li><span id="cit67">S. J. An, <span class="italic">et al.</span>, Thin film fabrication and simultaneous anodic reduction of deposited graphene oxide platelets by electrophoretic deposition, <span class="italic">J. Phys. Chem. Lett.</span>, 2010, <span class="bold">1</span>(8), 1259–1263 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jz100080c" title="DOI Link to resource 10.1021/jz100080c">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXjvFCjtLc%253D" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit68">Y. Sheng, <span class="italic">et al.</span>, Graphene oxide based fluorescent nanocomposites for cellular imaging, <span class="italic">J. Mater. Chem. B</span>, 2013, <span class="bold">1</span>(4), 512–521 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C2TB00123C&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C2TB00123C">RSC</a>.</span></li><li><span id="cit69">X. Li, <span class="italic">et al.</span>, Biocompatibility and toxicity of nanoparticles and nanotubes, <span class="italic">J. Nanomater.</span>, 2012, <span class="bold">2012</span>, 1–19 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=J.%20Nanomater.%5BJour%5D%20AND%202012%5Bvolume%5D%20AND%201%5Bpage%5D%20and%202012%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li><li><span id="cit70">S. H. Hu, <span class="italic">et al.</span>, Quantum-dot-tagged reduced graphene oxide nanocomposites for bright fluorescence bioimaging and photothermal therapy monitored in situ, <span class="italic">Adv. Mater.</span>, 2012, <span class="bold">24</span>(13), 1748–1754 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adma.201104070" title="DOI Link to resource 10.1002/adma.201104070">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38XktFSjsbk%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=22422734%5Buid%5D" title="PubMed Link to resource 22422734">PubMed</a>.</span></li><li><span id="cit71">X. Qin, <span class="italic">et al.</span>, Folic acid-conjugated graphene oxide for cancer targeted chemo-photothermal therapy, <span class="italic">J. Photochem. Photobiol., B</span>, 2013, <span class="bold">120</span>, 156–162 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.jphotobiol.2012.12.005" title="DOI Link to resource 10.1016/j.jphotobiol.2012.12.005">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXhsFCktro%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=23357205%5Buid%5D" title="PubMed Link to resource 23357205">PubMed</a>.</span></li><li><span id="cit72">E. S. Shibu, <span class="italic">et al.</span>, Nanomaterials formulations for photothermal and photodynamic therapy of cancer, <span class="italic">J. Photochem. Photobiol., C</span>, 2013, <span class="bold">15</span>, 53–72 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.jphotochemrev.2012.09.004" title="DOI Link to resource 10.1016/j.jphotochemrev.2012.09.004">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38XhslejsrbF" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit73">X. Huang, <span class="italic">et al.</span>, Plasmonic photothermal therapy (PPTT) using gold nanoparticles, <span class="italic">Lasers Med. Sci.</span>, 2008, <span class="bold">23</span>(3), 217 <a target="_blank" class="DOILink" href="https://doi.org/10.1007/s10103-007-0470-x" title="DOI Link to resource 10.1007/s10103-007-0470-x">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=17674122%5Buid%5D" title="PubMed Link to resource 17674122">PubMed</a>.</span></li><li><span id="cit74">L. Cheng, <span class="italic">et al.</span>, PEGylated WS2Nanosheets as a Multifunctional Theranostic Agent for in vivo Dual-Modal CT/Photoacoustic Imaging Guided Photothermal Therapy, <span class="italic">Adv. Mater.</span>, 2013, <span class="bold">26</span>(12), 1886–1893 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adma.201304497" title="DOI Link to resource 10.1002/adma.201304497">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=24375758%5Buid%5D" title="PubMed Link to resource 24375758">PubMed</a>.</span></li><li><span id="cit75">S. S. Chou, <span class="italic">et al.</span>, Chemically Exfoliated MoS2as Near-Infrared Photothermal Agents, <span class="italic">Angew. Chem., Int. Ed.</span>, 2013, <span class="bold">52</span>(15), 4160–4164 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.201209229" title="DOI Link to resource 10.1002/anie.201209229">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXjslKrsb8%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=23471666%5Buid%5D" title="PubMed Link to resource 23471666">PubMed</a>.</span></li><li><span id="cit76">P. K. Jain, <span class="italic">et al.</span>, Review of Some Interesting Surface Plasmon Resonance-enhanced Properties of Noble Metal Nanoparticles and Their Applications to Biosystems, <span class="italic">Plasmonics</span>, 2007, <span class="bold">2</span>(3), 107–118 <a target="_blank" class="DOILink" href="https://doi.org/10.1007/s11468-007-9031-1" title="DOI Link to resource 10.1007/s11468-007-9031-1">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2sXht1yitr3L" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit77">R. Jin, <span class="italic">et al.</span>, Controlling anisotropic nanoparticle growth through plasmon excitation, <span class="italic">Nature</span>, 2003, <span class="bold">425</span>(6957), 487–490 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/nature02020" title="DOI Link to resource 10.1038/nature02020">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD3sXnslSisb0%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=14523440%5Buid%5D" title="PubMed Link to resource 14523440">PubMed</a>.</span></li><li><span id="cit78">S. Lal, S. E. Clare and N. J. Halas, Nanoshell-Enabled Photothermal Cancer Therapy: Impending Clinical Impact, <span class="italic">Acc. Chem. Res.</span>, 2008, <span class="bold">41</span>(12), 1842–1851 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ar800150g" title="DOI Link to resource 10.1021/ar800150g">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1cXhtl2ltbzL" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit79">M. Li, <span class="italic">et al.</span>, Using Graphene Oxide High Near-Infrared Absorbance for Photothermal Treatment of Alzheimer's Disease, <span class="italic">Adv. Mater.</span>, 2012, <span class="bold">24</span>(13), 1722–1728 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adma.201104864" title="DOI Link to resource 10.1002/adma.201104864">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38XjsFGhtb8%253D" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit80">S. Thakur and N. Karak, Green reduction of graphene oxide by aqueous phytoextracts, <span class="italic">Carbon</span>, 2012, <span class="bold">50</span>(14), 5331–5339 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.carbon.2012.07.023" title="DOI Link to resource 10.1016/j.carbon.2012.07.023">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38XhtFClt7fF" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit81">Z. M. Markovic, <span class="italic">et al.</span>, In vitro comparison of the photothermal anticancer activity of graphene nanoparticles and carbon nanotubes, <span class="italic">Biomaterials</span>, 2011, <span class="bold">32</span>(4), 1121–1129 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2010.10.030" title="DOI Link to resource 10.1016/j.biomaterials.2010.10.030">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXhsVOntb3N" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit82">Z. Zhang, <span class="italic">et al.</span>, Mesoporous Silica-Coated Gold Nanorods as a Light-Mediated Multifunctional Theranostic Platform for Cancer Treatment, <span class="italic">Adv. Mater.</span>, 2012, <span class="bold">24</span>(11), 1418–1423 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adma.201104714" title="DOI Link to resource 10.1002/adma.201104714">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38XitFWrt7c%253D" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit83">G. Gollavelli and Y.-C. Ling, Multi-functional graphene as an in vitro and in vivo imaging probe, <span class="italic">Biomaterials</span>, 2012, <span class="bold">33</span>(8), 2532–2545 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2011.12.010" title="DOI Link to resource 10.1016/j.biomaterials.2011.12.010">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38XntFKrug%253D%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=22206596%5Buid%5D" title="PubMed Link to resource 22206596">PubMed</a>.</span></li><li><span id="cit84">S. H. Ku, M. Lee and C. B. Park, Carbon-Based Nanomaterials for Tissue Engineering, <span class="italic">Adv. Healthcare Mater.</span>, 2012, <span class="bold">2</span>(2), 244–260 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adhm.201200307" title="DOI Link to resource 10.1002/adhm.201200307">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=23184559%5Buid%5D" title="PubMed Link to resource 23184559">PubMed</a>.</span></li><li><span id="cit85">G. Lalwani, <span class="italic">et al.</span>, Two-Dimensional Nanostructure-Reinforced Biodegradable Polymeric Nanocomposites for Bone Tissue Engineering, <span class="italic">Biomacromolecules</span>, 2013, <span class="bold">14</span>(3), 900–909 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/bm301995s" title="DOI Link to resource 10.1021/bm301995s">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXitl2ksL0%253D" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit86">M. Pumera, Graphene in biosensing, <span class="italic">Mater. Today</span>, 2011, <span class="bold">14</span>(7–8), 308–315 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/S1369-7021(11)70160-2" title="DOI Link to resource 10.1016/S1369-7021(11)70160-2">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXos1Kjs7Y%253D" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit87">S. Sayyar, <span class="italic">et al.</span>, Covalently linked biocompatible graphene/polycaprolactone composites for tissue engineering, <span class="italic">Carbon</span>, 2013, <span class="bold">52</span>, 296–304 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.carbon.2012.09.031" title="DOI Link to resource 10.1016/j.carbon.2012.09.031">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38XhsFSltrrJ" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit88">B. Tian, <span class="italic">et al.</span>, Photothermally enhanced photodynamic therapy delivered by nano-graphene oxide, <span class="italic">ACS Nano</span>, 2011, <span class="bold">5</span>(9), 7000–7009 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/nn201560b" title="DOI Link to resource 10.1021/nn201560b">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXpvFChsbs%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21815655%5Buid%5D" title="PubMed Link to resource 21815655">PubMed</a>.</span></li><li><span id="cit89">C. Wang, <span class="italic">et al.</span>, Gold Nanoclusters and Graphene Nanocomposites for Drug Delivery and Imaging of Cancer Cells, <span class="italic">Angew. Chem., Int. Ed.</span>, 2011, <span class="bold">50</span>(49), 11644–11648 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.201105573" title="DOI Link to resource 10.1002/anie.201105573">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXht12qt7vM" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit90">Y. Wang, <span class="italic">et al.</span>, Nitrogen-Doped Graphene and Its Application in Electrochemical Biosensing, <span class="italic">ACS Nano</span>, 2010, <span class="bold">4</span>(4), 1790–1798 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/nn100315s" title="DOI Link to resource 10.1021/nn100315s">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXksVansrk%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=20373745%5Buid%5D" title="PubMed Link to resource 20373745">PubMed</a>.</span></li><li><span id="cit91">K. Yang, <span class="italic">et al.</span>, Nano-graphene in biomedicine: theranostic applications, <span class="italic">Chem. Soc. Rev.</span>, 2013, <span class="bold">42</span>(2), 530–547 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C2CS35342C&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C2CS35342C">RSC</a>.</span></li><li><span id="cit92">K. Yang, <span class="italic">et al.</span>, In vivo biodistribution and toxicology of functionalized nano-graphene oxide in mice after oral and intraperitoneal administration, <span class="italic">Biomaterials</span>, 2013, <span class="bold">34</span>(11), 2787–2795 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2013.01.001" title="DOI Link to resource 10.1016/j.biomaterials.2013.01.001">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXhtFahsbo%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=23340196%5Buid%5D" title="PubMed Link to resource 23340196">PubMed</a>.</span></li><li><span id="cit93">K. Yang, <span class="italic">et al.</span>, Multimodal imaging guided photothermal therapy using functionalized graphene nanosheets anchored with magnetic nanoparticles, <span class="italic">Adv. Mater.</span>, 2012, <span class="bold">24</span>(14), 1868–1872 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adma.201104964" title="DOI Link to resource 10.1002/adma.201104964">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38XjtVyiurk%253D" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit94">Y. Chen, <span class="italic">et al.</span>, Two-dimensional graphene analogues for biomedical applications, <span class="italic">Chem. Soc. Rev.</span>, 2015, <span class="bold">44</span>(9), 2681–2701 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C4CS00300D&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C4CS00300D">RSC</a>.</span></li><li><span id="cit95">W. Zhang, <span class="italic">et al.</span>, Synergistic effect of chemo-photothermal therapy using PEGylated graphene oxide, <span class="italic">Biomaterials</span>, 2011, <span class="bold">32</span>(33), 8555–8561 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2011.07.071" title="DOI Link to resource 10.1016/j.biomaterials.2011.07.071">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXhtFOlsrrJ" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21839507%5Buid%5D" title="PubMed Link to resource 21839507">PubMed</a>.</span></li><li><span id="cit96">J. Liu, <span class="italic">et al.</span>, Synthesis of phospholipid monolayer membrane functionalized graphene for drug delivery, <span class="italic">J. Mater. Chem.</span>, 2012, <span class="bold">22</span>(38), 20634–20640 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C2JM34494G&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C2JM34494G">RSC</a>.</span></li><li><span id="cit97">Y. W. Chen, <span class="italic">et al.</span>, NIR-triggered synergic photo-chemothermal therapy delivered by reduced graphene oxide/carbon/mesoporous silica nanocookies, <span class="italic">Adv. Funct. Mater.</span>, 2014, <span class="bold">24</span>(4), 451–459 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adfm.201301763" title="DOI Link to resource 10.1002/adfm.201301763">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXhtlagu7bP" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit98">C. Hu, <span class="italic">et al.</span>, Preparation of reduced graphene oxide and copper sulfide nanoplates composites as efficient photothermal agents for ablation of cancer cells, <span class="italic">Nano</span>, 2015, <span class="bold">10</span>(08), 1550123 <a target="_blank" class="DOILink" href="https://doi.org/10.1142/S1793292015501234" title="DOI Link to resource 10.1142/S1793292015501234">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXhvVyiu7fF" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit99">Z. Sheng, <span class="italic">et al.</span>, Protein-assisted fabrication of nano-reduced graphene oxide for combined in vivo photoacoustic imaging and photothermal therapy, <span class="italic">Biomaterials</span>, 2013, <span class="bold">34</span>(21), 5236–5243 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2013.03.090" title="DOI Link to resource 10.1016/j.biomaterials.2013.03.090">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXmt1Whurw%253D" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit100">D.-H. Hu, <span class="italic">et al.</span>, Hybrid gold–gadolinium nanoclusters for tumor-targeted NIRF/CT/MRI triple-modal imaging in vivo, <span class="italic">Nanoscale</span>, 2013, <span class="bold">5</span>(4), 1624–1628 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C2NR33543C&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C2NR33543C">RSC</a>.</span></li><li><span id="cit101">K. Yang, <span class="italic">et al.</span>, Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy, <span class="italic">Nano Lett.</span>, 2010, <span class="bold">10</span>(9), 3318–3323 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/nl100996u" title="DOI Link to resource 10.1021/nl100996u">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXpslWjsbw%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=20684528%5Buid%5D" title="PubMed Link to resource 20684528">PubMed</a>.</span></li><li><span id="cit102">T. Li, <span class="italic">et al.</span>, One-step reduction and PEIylation of PEGylated nanographene oxide for highly efficient chemo-photothermal therapy, <span class="italic">J. Mater. Chem. B</span>, 2016, <span class="bold">4</span>(17), 2972–2983 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C6TB00486E&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C6TB00486E">RSC</a>.</span></li><li><span id="cit103">K. Yang, <span class="italic">et al.</span>, The influence of surface chemistry and size of nanoscale graphene oxide on photothermal therapy of cancer using ultra-low laser power, <span class="italic">Biomaterials</span>, 2012, <span class="bold">33</span>(7), 2206–2214 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2011.11.064" title="DOI Link to resource 10.1016/j.biomaterials.2011.11.064">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38Xnt1egtw%253D%253D" title="Link to resource in CAS">CAS</a>.</span></li><li><span id="cit104">N. Rahmanian, <span class="italic">et al.</span>, Recent trends in targeted therapy of cancer using graphene oxide-modified multifunctional nanomedicines, <span class="italic">J. Drug Targeting</span>, 2017, <span class="bold">25</span>(3), 202–215 <a target="_blank" class="DOILink" href="https://doi.org/10.1080/1061186X.2016.1238475" title="DOI Link to resource 10.1080/1061186X.2016.1238475">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28Xhs1CnsrfF" title="Link to resource in CAS">CAS</a>.</span></li></ol>




<hr/><table><tr><td><h3>Footnote</h3></td></tr><tr><td><span class="sup_ref">† <span id="fn1">Electronic supplementary information (ESI) available. See DOI: <a href="http://xlink.rsc.org/?DOI=d0ra00186d" target="_blank" title="Select to resolve DOI: 10.1039/d0ra00186d">10.1039/d0ra00186d</a></span></span></td></tr></table><table><tr><td><hr/></td></tr><tr><td><b>This journal is © The Royal Society of Chemistry 2020</b></td></tr></table></div></div></div></body><script src="/content/scripts/CrossMarkIE.js"> </script><SaxonLicenceTest result="pass" message="Licenced Enterprise Edition [ EE 9.3.0.4 ]"/></html>